HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 18JUN21:06:47:2118JUN21:06:47:21 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SV SASDATA 9.4 X64_SR12 18JUN21:06:47:2118JUN21:06:47:21 Subject Visits HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001400000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier  SUBJID Subject Identifier for the Study )SVSEQ Sequence Number 2VISITNUMVisit Number :"VISIT Visit Name BVISITDY Planned Study Day of Visit d EPOCH Epoch l SVSTDTC Start Date/Time of Visit  SVENDTC End Date/Time of Visit  SVSTDY Study Day of Start of Visit  SVENDY Study Day of End of Visit SVUPDES Description of Unplanned Visit HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201SVmRNA-1273-P201-US201-1001US2011001AAScreening SCREENING 2020-05-262020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US201-1003US2011003AAScreening SCREENING 2020-05-262020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BzBz mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-052021-03-05C`C` mRNA-1273-P201SVmRNA-1273-P201-US201-1004US2011004BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1005US2011005AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US201-1006US2011006AAScreening SCREENING 2020-05-262020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1007US2011007BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1008US2011008AAScreening SCREENING 2020-05-262020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009A0A (\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-012020-06-01AAPPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1009US2011009AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-032020-07-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-102020-07-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-242020-07-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BuBu mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-162020-11-16BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1011US2011011BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29ByBy mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1012US2011012ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01B{B{ mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1014US2011014BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-222021-03-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US201-1015US2011015AAScreening SCREENING 2020-05-262020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-15B,B- mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BzBz mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US201-1018US2011018BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11CC mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1019US2011019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BzBz mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1020US2011020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11CC mRNA-1273-P201SVmRNA-1273-P201-US201-1021US2011021AAScreening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1022US2011022AAScreening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1023US2011023ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1024US2011024AAScreening SCREENING 2020-05-272020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1027US2011027AAScreening SCREENING 2020-05-272020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BuBu mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028AA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-052021-02-05BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1028US2011028BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-152021-03-15CC mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1029US2011029BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1030US2011030BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03C0C0 mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-052021-03-05CPCP mRNA-1273-P201SVmRNA-1273-P201-US201-1032US2011032BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1033US2011033AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1034US2011034AAScreening SCREENING 2020-05-272020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1035US2011035AAScreening SCREENING 2020-05-272020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1037US2011037AAScreening SCREENING 2020-05-272020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-092020-11-09BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1039US2011039BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-152021-03-15CC mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1040US2011040AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041BBSafety Call Day 265 CPART A FOLLOW-UP 2021-03-042021-03-04C@C@ mRNA-1273-P201SVmRNA-1273-P201-US201-1041US2011041BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BRBR mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BsBs mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-022021-03-02CC mRNA-1273-P201SVmRNA-1273-P201-US201-1042US2011042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-152021-03-15CC mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AAScreening SCREENING 2020-05-272020-05-29P0 mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-222021-01-22BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1043US2011043ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1045US2011045AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01BzBz mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1046US2011046BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B^B^ mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1048US2011048ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1049US2011049AAScreening SCREENING 2020-05-272020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1050US2011050ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01B\B\ mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-122020-10-12BB mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-192020-10-19BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051BBSafety Call Day 265 CPART A FOLLOW-UP 2021-03-012021-03-01CC mRNA-1273-P201SVmRNA-1273-P201-US201-1051US2011051BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1052US2011052AAScreening SCREENING 2020-05-272020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1053US2011053AAScreening SCREENING 2020-05-272020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US201-1054US2011054AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1055US2011055AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1056US2011056BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1057US2011057BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-172021-03-17CC mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30ByBy mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1059US2011059BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-122021-03-12CC mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1060US2011060BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-182020-06-18BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BsBs mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1061US2011061BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1062US2011062AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1063US2011063AAScreening SCREENING 2020-05-282020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1064US2011064BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-172021-03-17CC mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1065US2011065BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1066US2011066AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067A0A0Visit 2 Day 8 A .. mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-152020-06-15AACentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-07BB# mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067ApAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-022020-07-02BBPPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BABA mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B\B\ mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-102020-11-10BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1067US2011067BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11CC mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1068US2011068BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01BzBz mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1069US2011069BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070A0A0Visit 2 Day 8 A .. mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US201-1070US2011070AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B?B? mRNA-1273-P201SVmRNA-1273-P201-US201-1071US2011071AAScreening SCREENING 2020-05-282020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1072US2011072AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1074US2011074AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1075US2011075AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1076US2011076AAScreening SCREENING 2020-05-292020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1077US2011077AAScreening SCREENING 2020-05-292020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US201-1078US2011078AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US201-1079US2011079AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BsBs mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-022021-03-02CC mRNA-1273-P201SVmRNA-1273-P201-US201-1080US2011080BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11CC mRNA-1273-P201SVmRNA-1273-P201-US201-1083US2011083AAScreening SCREENING 2020-05-292020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1084US2011084BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085BBSafety Call Day 265 CPART A FOLLOW-UP 2021-03-052021-03-05C@C@ mRNA-1273-P201SVmRNA-1273-P201-US201-1085US2011085BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US201-1086US2011086BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1087US2011087BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B>B> mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-282020-10-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088ABSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US201-1088US2011088BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AAScreening SCREENING 2020-06-012020-06-01@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-302020-06-30BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B5B5 mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-022020-10-02BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-302020-10-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-252020-11-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US201-1089US2011089BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-122021-03-12CC mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-212021-01-21BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US201-1090US2011090BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CC mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B=B= mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-242020-11-24BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US201-1091US2011091BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CpCp mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BYBY mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-022020-10-02BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-012021-03-01CC mRNA-1273-P201SVmRNA-1273-P201-US201-1092US2011092BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10CpCp mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US201-1093US2011093ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-182021-03-18CC mRNA-1273-P201SVmRNA-1273-P201-US201-1094US2011094AAScreening SCREENING 2020-06-032020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01BwBw mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-152020-12-15BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095BBSafety Call Day 265 CPART A FOLLOW-UP 2021-03-012021-03-01CC mRNA-1273-P201SVmRNA-1273-P201-US201-1095US2011095BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-122021-03-12CC mRNA-1273-P201SVmRNA-1273-P201-US201-1096US2011096AAScreening SCREENING 2020-06-032020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US201-1097US2011097AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US201-1098US2011098AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US201-1099US2011099AAScreening SCREENING 2020-06-032020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US201-1100US2011100AAScreening SCREENING 2020-06-042020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US201-1101US2011101AAScreening SCREENING 2020-06-042020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-022020-10-02BuBu mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102ABSafety Call Day 265 CPART A FOLLOW-UP 2021-03-012021-03-01CC mRNA-1273-P201SVmRNA-1273-P201-US201-1102US2011102BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09C0C0 mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BsBs mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1103US2011103ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09C0C0 mRNA-1273-P201SVmRNA-1273-P201-US201-1104US2011104AAScreening SCREENING 2020-06-082020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US201-1105US2011105AAScreening SCREENING 2020-06-082020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1106US2011106AAScreening SCREENING 2020-06-092020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1107US2011107AAScreening SCREENING 2020-06-092020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1108US2011108AAScreening SCREENING 2020-06-092020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-302020-09-30BaBa mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BxBx mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-022021-03-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1109US2011109BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US201-1111US2011111AAScreening SCREENING 2020-06-112020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1112US2011112AAScreening SCREENING 2020-06-112020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1113US2011113AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-042021-03-04BB mRNA-1273-P201SVmRNA-1273-P201-US201-1114US2011114BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08CC mRNA-1273-P201SVmRNA-1273-P201-US201-1115US2011115AAScreening SCREENING 2020-06-122020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US201-1115US2011115A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-272020-06-27AA mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1116US2011116ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-042021-03-04BB mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BYBY mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1117US2011117ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-022021-03-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28B_B_ mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-042021-03-04BB mRNA-1273-P201SVmRNA-1273-P201-US201-1118US2011118ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1119US2011119AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-272020-06-27AA mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B_B_ mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BuBu mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-022021-03-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1120US2011120ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08BB mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-142020-08-14B,B,Physical Exam; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BZBZ mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1121US2011121ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122A`A`Visit 5 Day 36 B$ .. mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122ApApVisit 6 Day 43 B+ .. mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-052021-03-05BB mRNA-1273-P201SVmRNA-1273-P201-US201-1122US2011122BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011025APrevious Screening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123A AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-302020-09-30BaBa mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1123US2011123BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10C C mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011081APrevious Screening SCREENING 2020-05-292020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124A AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BYBY mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1124US2011124BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-022021-03-02BB mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011017APrevious Screening SCREENING 2020-05-262020-06-16% mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125A AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B#B# mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BZBZ mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1125US2011125ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011038APrevious Screening SCREENING 2020-05-272020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1126US2011126BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011013APrevious Screening SCREENING 2020-05-262020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BZBZ mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-152020-12-15BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-082021-02-08BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BAQPVisit 8 Day 209 Unscheduled 2 .PART A FOLLOW-UP 2021-03-092021-03-09CCPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BBSafety Call Day 265 CPART A FOLLOW-UP 2021-03-162021-03-16CC mRNA-1273-P201SVmRNA-1273-P201-US201-1127US2011127BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-302021-03-30C`C` mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011047APrevious Screening SCREENING 2020-05-272020-06-16" mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B,B, mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B\B\ mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BsBs mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1128US2011128BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011073APrevious Screening SCREENING 2020-05-282020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-262020-09-26B]B] mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1130US2011130BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08CC mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BvBv mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131AASafety Call Day 237 BPART A FOLLOW-UP 2021-03-052021-03-05BB mRNA-1273-P201SVmRNA-1273-P201-US201-1131US2011131ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09CC mRNA-1273-P201SVmRNA-1273-P201-US201-1132US2011026APrevious Screening SCREENING 2020-05-272020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US201-1132US2011132A AScreening SCREENING 2020-06-182020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1133US2011133AAScreening SCREENING 2020-06-182020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1134US2011134AAScreening SCREENING 2020-06-192020-07-03.. mRNA-1273-P201SVmRNA-1273-P201-US201-1135US2011135AAScreening SCREENING 2020-06-192020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1136US2011136AAScreening SCREENING 2020-06-192020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1136US2011136A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011058APrevious Screening SCREENING 2020-05-282020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137A AScreening SCREENING 2020-06-222020-06-22@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-192020-08-19B7B7 mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137BASafety Call Day 237 BPART A FOLLOW-UP 2021-03-052021-03-05BB mRNA-1273-P201SVmRNA-1273-P201-US201-1137US2011137BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10C C mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011031APrevious Screening SCREENING 2020-05-272020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138A AScreening SCREENING 2020-06-222020-06-22PP mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-272020-06-27AA mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B=B= mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B_B_ mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BvBv mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1138US2011138ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139AAScreening SCREENING 2020-06-222020-06-22@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1139US2011139AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BZBZ mRNA-1273-P201SVmRNA-1273-P201-US201-1140US2011016APrevious Screening SCREENING 2020-05-262020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US201-1140US2011140A AScreening SCREENING 2020-06-222020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011044APrevious Screening SCREENING 2020-05-272020-06-16! mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142A AScreening SCREENING 2020-06-222020-06-22pp mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B&B& mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-062020-10-06BdBd mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1142US2011142ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08BB mRNA-1273-P201SVmRNA-1273-P201-US201-1143US2011143AAScreening SCREENING 2020-06-232020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US201-1144US2011144AAScreening SCREENING 2020-06-232020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AAScreening SCREENING 2020-06-232020-06-2300 mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-202020-08-20B8B8 mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BYBY mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1145US2011145ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US201-1146US2011082APrevious Screening SCREENING 2020-05-292020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1146US2011146A AScreening SCREENING 2020-06-242020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US201-1147US2011147AAScreening SCREENING 2020-06-242020-06-26.. mRNA-1273-P201SVmRNA-1273-P201-US201-1148US2011148AAScreening SCREENING 2020-06-252020-06-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011010APrevious Screening SCREENING 2020-05-262020-05-28" mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149A AScreening SCREENING 2020-06-252020-06-25@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B@B@ mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1149US2011149BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-012021-03-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1150US2011129APrevious Screening SCREENING 2020-06-182020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US201-1150US2011150A AScreening SCREENING 2020-06-252020-06-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1151US2011151AAScreening SCREENING 2020-06-252020-06-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AAScreening SCREENING 2020-06-252020-06-25@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B@B@ mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B]B] mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1152US2011152ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011141APrevious Screening SCREENING 2020-06-222020-06-24pP mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153A AScreening SCREENING 2020-06-252020-06-25@@ mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1153US2011153BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1154US2011002APrevious Screening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1154US2011154A AScreening SCREENING 2020-06-252020-06-27.. mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AAScreening SCREENING 2020-06-252020-06-25PP mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B\B\ mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-222021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US201-1155US2011155ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09BB mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AAScreening SCREENING 2020-06-252020-06-25PP mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29B\B\ mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1156US2011156AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011110APrevious Screening SCREENING 2020-06-112020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157A AScreening SCREENING 2020-06-252020-06-30PA mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B;B; mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28B[B[ mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1157US2011157BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08BB mRNA-1273-P201SVmRNA-1273-P201-US201-1158US2011036APrevious Screening SCREENING 2020-05-272020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US201-1158US2011158A AScreening SCREENING 2020-06-262020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AAScreening SCREENING 2020-06-302020-06-30 mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BZBZ mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BuBu mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-232021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US201-1159US2011159BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10BB mRNA-1273-P201SVmRNA-1273-P201-US201-1160US2011160AAScreening SCREENING 2020-06-302020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US201-1161US2011161AAScreening SCREENING 2020-07-012020-07-03.. mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AAScreening SCREENING 2020-07-012020-07-01PP mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-302020-09-30BWBW mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-262021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US201-1162US2011162ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09BB mRNA-1273-P201SVmRNA-1273-P201-US202-1001US2021001AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1002US2021002AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-052020-08-05BEBECentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BYBY mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-182021-02-18CC mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003BBSafety Call Day 293 CPPART A FOLLOW-UP 2021-03-152021-03-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1003US2021003BBParticipant Decision Visit / OL-D1. .. mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-242020-07-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-192020-08-19BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-152021-02-15CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1004US2021004BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-052021-03-05CC mRNA-1273-P201SVmRNA-1273-P201-US202-1005US2021005AAScreening SCREENING 2020-05-262020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US202-1005US2021005A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-06-302020-06-30BBPhysical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B;B; mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-062020-08-06BCBCCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1007US2021007BBParticipant Decision Visit / OL-D1. 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US202-1008US2021008AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1009US2021009AAScreening SCREENING 2020-05-262020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-212020-07-21B6B6 mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-182020-08-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1011US2021011BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1012US2021012BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1013US2021013AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1014US2021014AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-232020-07-23B8B8 mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-192020-08-19BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1015US2021015BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1017US2021017AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-292020-06-29B B Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-222020-07-22B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-222020-07-22B7B7Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-292020-07-29B>B> mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BKBK mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-152020-10-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1018US2021018BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B#B# mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-112020-08-11BKBKCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BZBZ mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-262021-01-26BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1019US2021019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CC mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B;B; mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1020US2021020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-222020-07-22B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-202020-08-20BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US202-1021US2021021AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B3B3 mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04BABA mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-072020-09-07BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1022US2021022BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1025US2021025AAScreening SCREENING 2020-05-262020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US202-1026US2021026AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1027US2021027AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1028US2021028AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1030US2021030AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BtBt mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1031US2021031BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1032US2021032AAScreening SCREENING 2020-05-262020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1032US2021032A A(\)Screening Unscheduled 1 .SCREENING 2020-06-102020-06-10..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1033US2021033AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1034US2021034AAScreening SCREENING 2020-05-262020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US202-1034US2021034A A(\)Screening Unscheduled 1 .SCREENING 2020-06-112020-06-11..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1036US2021036AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1037US2021037AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1038US2021038AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1041US2021041AAScreening SCREENING 2020-05-272020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1041US2021041A A(\)Screening Unscheduled 1 .SCREENING 2020-06-102020-06-10..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B B mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B;B; mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1043US2021043BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-022020-11-02BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-302020-11-30BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1045US2021045BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-242020-07-24B6B6 mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1047US2021047BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1048US2021048AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1049US2021049AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1050US2021050AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1051US2021051AAScreening SCREENING 2020-05-272020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1052US2021052AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1053US2021053AAScreening SCREENING 2020-05-272020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1053US2021053A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1054US2021054AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1055US2021055AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1055US2021055A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1056US2021056AAScreening SCREENING 2020-05-272020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1056US2021056A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1057US2021057AAScreening SCREENING 2020-05-272020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058ApAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-082020-07-08B"B"Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-092020-09-09BaBa mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1058US2021058BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1059US2021059BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1060US2021060AAScreening SCREENING 2020-05-272020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1060US2021060A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1061US2021061BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062A`A@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-262020-06-26BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B6B6 mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-262021-01-26BBPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US202-1062US2021062BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CPCP mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B?B? mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B\B\ mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-282021-01-28BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1063US2021063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-042021-03-04C C mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064A`A@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-302020-06-30BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-242020-11-24BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064BASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1064US2021064BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-192021-03-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1065US2021065AAScreening SCREENING 2020-05-272020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1065US2021065A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1066US2021066AAScreening SCREENING 2020-05-272020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US202-1066US2021066A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B?B? mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BZBZ mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1067US2021067BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1068US2021068BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US202-1069US2021069AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US202-1071US2021071AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1071US2021071A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1072US2021072AAScreening SCREENING 2020-05-282020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US202-1072US2021072A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-172020-11-17BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AAQPSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-092020-12-09BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-072021-01-07BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1073US2021073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01B\B\ mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1074US2021074BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-152021-03-15CC mRNA-1273-P201SVmRNA-1273-P201-US202-1075US2021075AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1075US2021075A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1077US2021077AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1078US2021078BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1079US2021079AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1079US2021079A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-0200Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-092020-09-09BaBa mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1080US2021080BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-042021-03-04CC mRNA-1273-P201SVmRNA-1273-P201-US202-1081US2021081AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BBBB mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B\B\ mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-102020-09-10BdBdVital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-082020-10-08BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1082US2021082BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1083US2021083AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1083US2021083A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-0200Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1084US2021084BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1085US2021085AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1086US2021086AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1087US2021087AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1087US2021087A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1088US2021088AAScreening SCREENING 2020-05-282020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US202-1088US2021088A A(\)Screening Unscheduled 1 .SCREENING 2020-06-102020-06-10..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1089US2021089BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-072020-09-07BbBb mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1090US2021090ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1091US2021091AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1092US2021092AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BABA mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-112020-09-11BeBe mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US202-1093US2021093BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-022021-03-02CC mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-0200Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094ApAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-062020-07-06B B Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AA`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B?B? mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-092020-09-09BaBaCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094BASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1094US2021094BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1095US2021095AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1095US2021095A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-152020-11-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US202-1096US2021096BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1097US2021097AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1097US2021097A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1098US2021098AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1098US2021098A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-072020-08-07BCBCPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1099US2021099BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US202-1100US2021100AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1100US2021100A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1101US2021101BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-022021-03-02CC mRNA-1273-P201SVmRNA-1273-P201-US202-1102US2021102AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1102US2021102A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1103US2021103AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1105US2021105AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1105US2021105A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-112020-09-11BeBeVital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1107US2021107BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1108US2021108AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US202-1109US2021109AAScreening SCREENING 2020-05-292020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US202-1109US2021109A A(\)Screening Unscheduled 1 .SCREENING 2020-06-112020-06-11..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1110US2021110AAScreening SCREENING 2020-05-292020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1110US2021110A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AAScreening SCREENING 2020-05-292020-05-29 mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111A`A@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-132020-07-13B$B$Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-302020-07-30B5B5 mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-172020-08-17BGBG mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-252021-01-25BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1111US2021111BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1112US2021112AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1113US2021113AAScreening SCREENING 2020-05-292020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1113US2021113A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AAScreening SCREENING 2020-05-292020-05-29 mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BuBu mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1114US2021114ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AAScreening SCREENING 2020-05-292020-05-29 mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1115US2021115BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1116US2021116AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1117US2021117AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1118US2021118AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1119US2021119AAScreening SCREENING 2020-05-292020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1119US2021119A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1120US2021120AAScreening SCREENING 2020-05-292020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1120US2021120A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-312020-12-31BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1121US2021121BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-192021-03-19C C mRNA-1273-P201SVmRNA-1273-P201-US202-1122US2021122AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1123US2021123AAScreening SCREENING 2020-05-292020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1123US2021123A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1124US2021124AAScreening SCREENING 2020-05-292020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1124US2021124A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1125US2021125AAScreening SCREENING 2020-06-012020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1125US2021125A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1126US2021126AAScreening SCREENING 2020-06-012020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1127US2021127AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1128US2021128AAScreening SCREENING 2020-06-012020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1128US2021128A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1129US2021129AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AAScreening SCREENING 2020-06-012020-06-01 mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B?B? mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1130US2021130BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1131US2021131AAScreening SCREENING 2020-06-012020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1131US2021131A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1132US2021132AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AAScreening SCREENING 2020-06-012020-06-01 mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B?B? mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1133US2021133ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1134US2021134AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AAScreening SCREENING 2020-06-012020-06-01@@ mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1135US2021135BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-042021-03-04CC mRNA-1273-P201SVmRNA-1273-P201-US202-1136US2021136AAScreening SCREENING 2020-06-012020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1136US2021136A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AAScreening SCREENING 2020-06-012020-06-01pp mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-112020-08-11BABACentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18BHBH mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BWBW mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1137US2021137BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-192021-03-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BDBD mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B[B[ mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-082021-02-08BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1138US2021138BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US202-1139US2021139AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1140US2021140AAScreening SCREENING 2020-06-022020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1141US2021141AAScreening SCREENING 2020-06-022020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US202-1142US2021142AAScreening SCREENING 2020-06-022020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US202-1143US2021143AAScreening SCREENING 2020-06-022020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1143US2021143A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-312020-07-31B9B9Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1144US2021144BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AAScreening SCREENING 2020-06-022020-06-02 mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BFBF mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-092020-09-09BbBb mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US202-1145US2021145BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1146US2021146AAScreening SCREENING 2020-06-022020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-092020-12-09BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1147US2021147BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1148US2021148AAScreening SCREENING 2020-06-022020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1148US2021148A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1149US2021149AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1150US2021150AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1150US2021150A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-0500Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-252020-06-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-232020-07-23B.B.Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1151US2021151BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CC mRNA-1273-P201SVmRNA-1273-P201-US202-1152US2021152AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1153US2021153AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1153US2021153A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-092020-09-09BaBa mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-132020-10-13BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1154US2021154BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-292020-07-29B4B4 mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BBBB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-172020-08-17BGBGPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-232020-09-23BlBlCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155BASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1155US2021155BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1156US2021156AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1156US2021156A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1157US2021157AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1157US2021157A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1158US2021158AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1158US2021158A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1159US2021159AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1160US2021160AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-0500Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1161US2021161BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CPCP mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162A0A0Visit 2 Day 8 APART A FOLLOW-UP 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162A@A@Visit 3 Day 15 APART A FOLLOW-UP 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162APAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162A`AP(\(Visit 4 Day 29 Unscheduled 1 .PART A FOLLOW-UP 2020-07-132020-07-13B$B$Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162ApA`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BdBd mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-302020-11-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1162US2021162BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-182021-03-18CC mRNA-1273-P201SVmRNA-1273-P201-US202-1163US2021163AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164A0A (\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-102020-06-10A0A0Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-142020-10-14BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-222020-11-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1164US2021164BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CPCP mRNA-1273-P201SVmRNA-1273-P201-US202-1165US2021165AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166BB\(Safety Call Day 265 Unscheduled 1 .PART A FOLLOW-UP 2021-03-182021-03-18CCVital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1166US2021166BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-04-022021-04-02CC mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-292020-10-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-302020-11-30BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1167US2021167BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1168US2021168AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US202-1169US2021169AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US202-1170US2021170AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1170US2021170A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1171US2021171AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US202-1172US2021172AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US202-1173US2021173AAScreening SCREENING 2020-06-042020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1174US2021174AAScreening SCREENING 2020-06-042020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1174US2021174A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AAScreening SCREENING 2020-06-042020-06-04@@ mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-132020-10-13BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-282020-10-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-132020-11-13BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1175US2021175BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1176US2021176AAScreening SCREENING 2020-06-042020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US202-1177US2021177AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1177US2021177A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1178US2021178AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-082020-10-08B{B{Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-062021-01-06BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1179US2021179BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-142020-09-14BcBc mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US202-1180US2021180BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1181US2021181AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B6B6 mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-282020-10-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US202-1182US2021182BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-052021-03-05CC mRNA-1273-P201SVmRNA-1273-P201-US202-1183US2021183AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1184US2021184AAScreening SCREENING 2020-06-102020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B5B5 mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-092021-02-09BBVital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1185US2021185BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-102021-03-10C C mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1186US2021186BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1187US2021187AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US202-1188US2021188AAScreening SCREENING 2020-06-112020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-302020-12-30BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1189US2021189BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-03-022021-03-02BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1190US2021190BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-192021-03-19CC mRNA-1273-P201SVmRNA-1273-P201-US202-1191US2021191AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-302020-11-30BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1192US2021192BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-152021-03-15CpCp mRNA-1273-P201SVmRNA-1273-P201-US202-1193US2021193AAScreening SCREENING 2020-06-122020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US202-1194US2021194AAScreening SCREENING 2020-06-122020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US202-1194US2021194A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1195US2021195AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B0B0 mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1196US2021196AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1197US2021197AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B3B3 mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01BABA mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1198US2021198AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1199US2021199AAScreening SCREENING 2020-06-152020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US202-1201US2021201AAScreening SCREENING 2020-06-152020-07-07.. mRNA-1273-P201SVmRNA-1273-P201-US202-1202US2021006APrevious Screening SCREENING 2020-05-262020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US202-1202US2021006A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1202US2021202A0AScreening SCREENING 2020-06-162020-06-26.. mRNA-1273-P201SVmRNA-1273-P201-US202-1202US2021202A@A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1203US2021203AAScreening SCREENING 2020-06-162020-07-07.. mRNA-1273-P201SVmRNA-1273-P201-US202-1203US2021203A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1203US2021203A0AQRScreening Unscheduled 2 .SCREENING 2020-07-022020-07-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1204US2021204AAScreening SCREENING 2020-06-162020-06-16.. mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021035APrevious Screening SCREENING 2020-05-272020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205A AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-02-032021-02-03BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1205US2021205BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021029APrevious Screening SCREENING 2020-05-262020-06-17% mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021029A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206A0AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04B"B" mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BEBE mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-162020-09-16BMBMCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206BASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US202-1206US2021206BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021104APrevious Screening SCREENING 2020-05-282020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021104A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207A0AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03BFBF mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-232020-09-23BZBZCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-192020-10-19BtBtCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207BASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1207US2021207BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021044APrevious Screening SCREENING 2020-05-272020-06-17# mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208A AScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208A0A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AAP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-072020-08-07B&B&Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B)B) mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B2B2 mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BFBF mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208BA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-072021-01-07BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1208US2021208BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1209US2021046APrevious Screening SCREENING 2020-05-272020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US202-1209US2021209A AScreening SCREENING 2020-06-182020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US202-1209US2021209A0A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1210US2021042APrevious Screening SCREENING 2020-05-272020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US202-1210US2021042A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1210US2021210A0AScreening SCREENING 2020-06-182020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1210US2021210A@A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021010APrevious Screening SCREENING 2020-05-262020-06-18% mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1211US2021211BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1212US2021212AAScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US202-1213US2021076APrevious Screening SCREENING 2020-05-282020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US202-1213US2021076A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-112020-06-11..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1213US2021213A0AScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021040APrevious Screening SCREENING 2020-05-272020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021040A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214A0AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-202020-08-20B8B8 mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-112020-09-11BNBNPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1214US2021214BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11C0C0 mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021070APrevious Screening SCREENING 2020-05-272020-06-18! mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B4B4 mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BHBH mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-082020-09-08BHBHCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1215US2021215BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021039APrevious Screening SCREENING 2020-05-272020-06-19$ mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021039A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216A0AScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216A@A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216APA Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216A`A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216ApA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-222021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1216US2021216BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-022021-03-02BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021200APrevious Screening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217A AScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217A0A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B;B; mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217BASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US202-1217US2021217BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021106APrevious Screening SCREENING 2020-05-282020-06-23!p mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218A AScreening SCREENING 2020-06-232020-06-23pp mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B B mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-122020-10-12BiBiPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1218US2021218BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021024APrevious Screening SCREENING 2020-05-262020-06-23#p mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021024A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-112020-06-11Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219A0AScreening SCREENING 2020-06-232020-06-23pp mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B B mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-112020-08-11B+B+Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B.B. mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03BBBB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BrBr mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1219US2021219BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021016APrevious Screening SCREENING 2020-05-262020-06-24"P mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021016A ?(\(Previous Screening Unscheduled 1 .SCREENING 2020-06-102020-06-10Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220A0AScreening SCREENING 2020-06-242020-06-24PP mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US202-1220US2021220BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1221US2021221AAScreening SCREENING 2020-06-292020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1221US2021221A A(\)Screening Unscheduled 1 .SCREENING 2020-07-062020-07-06..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021023APrevious Screening SCREENING 2020-05-262020-06-24% mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222A AScreening SCREENING 2020-06-292020-06-2900 mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B7B7 mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BSBS mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US202-1222US2021222BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US202-1223US2021223AAScreening SCREENING 2020-06-292020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US202-1224US2021224AAScreening SCREENING 2020-06-302020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US202-1225US2021225AAScreening SCREENING 2020-06-302020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1225US2021225A A(\)Screening Unscheduled 1 .SCREENING 2020-07-062020-07-06..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-08-052020-08-05BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-142020-08-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-172020-08-17B+B+Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226BA(\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-01-152021-01-15BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226BAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-242021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US202-1226US2021226BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US202-1227US2021227AAScreening SCREENING 2020-06-012020-07-01.. mRNA-1273-P201SVmRNA-1273-P201-US202-1228US2021228AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1228US2021228A A(\)Screening Unscheduled 1 .SCREENING 2020-07-072020-07-07..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1229US2021229AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1229US2021229A A(\)Screening Unscheduled 1 .SCREENING 2020-07-072020-07-07..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AAScreening SCREENING 2020-07-012020-07-06PA mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-062021-01-06BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230AA(\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2021-02-052021-02-05BBCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1230US2021230BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1231US2021231AAScreening SCREENING 2020-07-022020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1231US2021231A A(\)Screening Unscheduled 1 .SCREENING 2020-07-062020-07-06..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AAScreening SCREENING 2020-07-022020-07-02@@ mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06B B mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-102020-09-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-102020-09-10BCBCCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-132020-10-13BdBdPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BnBn mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1232US2021232BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1233US2021233AAScreening SCREENING 2020-07-022020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1233US2021233A A(\)Screening Unscheduled 1 .SCREENING 2020-07-062020-07-06..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AAScreening SCREENING 2020-07-022020-07-02PP mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B$B$ mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B*B* mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B;B; mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BTBT mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BpBp mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US202-1234US2021234ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US202-1235US2021235AAScreening SCREENING 2020-07-062020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1236US2021236AAScreening SCREENING 2020-07-062020-07-06.. mRNA-1273-P201SVmRNA-1273-P201-US202-1237US2021237AAScreening SCREENING 2020-07-062020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1238US2021238AAScreening SCREENING 2020-07-062020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1239US2021239AAScreening SCREENING 2020-07-062020-07-06.. mRNA-1273-P201SVmRNA-1273-P201-US202-1240US2021240AAScreening SCREENING 2020-07-072020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US202-1241US2021241AAScreening SCREENING 2020-07-072020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B0B0 mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B>B> mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BZBZ mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1001US2031001BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1002US2031002BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1003US2031003AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1003US2031003A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-012020-07-01B"B"Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B1B1 mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03BCBC mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27B[B[ mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-152020-10-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-042020-11-04BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1004US2031004BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09CC mRNA-1273-P201SVmRNA-1273-P201-US203-1005US2031005AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1006US2031006AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1007US2031007AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1007US2031007A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1008US2031008AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-192020-10-19BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1009US2031009BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1010US2031010AAScreening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US203-1010US2031010A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B1B1 mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05BEBE mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BXBX mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-072021-01-07BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-152021-02-15CpCp mRNA-1273-P201SVmRNA-1273-P201-US203-1011US2031011BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16CC mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1012US2031012BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-022021-02-02BBVital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1013US2031013BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1014US2031014BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1015US2031015AAScreening SCREENING 2020-05-262020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B6B6 mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-082020-10-08BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US203-1016US2031016BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11CC mRNA-1273-P201SVmRNA-1273-P201-US203-1017US2031017AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1017US2031017A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1018US2031018AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1018US2031018A A(\)Screening Unscheduled 1 .SCREENING 2020-05-262020-05-26..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1018US2031018A0AQRScreening Unscheduled 2 .SCREENING 2020-05-282020-05-28..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B#B# mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B2B2 mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B?B? mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-302020-08-30B^B^ mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BxBx mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1019US2031019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B0B0 mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03BCBC mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BXBX mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BwBw mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1020US2031020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1021US2031021BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1022US2031022BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11C0C0 mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B#B# mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B1B1 mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28B\B\ mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1023US2031023BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1024US2031024AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1024US2031024A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1025US2031025AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-242020-07-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-182020-08-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-152020-10-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1026US2031026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09CC mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1027US2031027BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11CC mRNA-1273-P201SVmRNA-1273-P201-US203-1028US2031028AAScreening SCREENING 2020-05-272020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1028US2031028A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31B[B[ mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1029US2031029BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-292020-08-29BXBX mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1030US2031030BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1031US2031031AAScreening  2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1031US2031031A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1032US2031032AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-142020-12-14BBVital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1033US2031033BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1034US2031034AAScreening  2020-05-262020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-142020-09-14BjBjPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1035US2031035BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11CC mRNA-1273-P201SVmRNA-1273-P201-US203-1036US2031036AAScreening SCREENING 2020-05-272020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1036US2031036A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1037US2031037BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-192021-02-19C`C` mRNA-1273-P201SVmRNA-1273-P201-US203-1038US2031038BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US203-1039US2031039AAScreening SCREENING 2020-05-272020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BYBY mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-142020-12-14BBVital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US203-1040US2031040BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-082020-07-08B%B%Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BsBs mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1041US2031041BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-272021-02-27CC mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B=B= mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1042US2031042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1043US2031043BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1044US2031044AAScreening SCREENING 2020-05-272020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1044US2031044A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1045US2031045AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US203-1045US2031045A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1045US2031045A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1045US2031045A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1045US2031045APAPVisit 4 Day 29 B .. mRNA-1273-P201SVmRNA-1273-P201-US203-1046US2031046AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-012020-07-01BBPhysical Exam mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1047US2031047BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AAScreening SCREENING 2020-05-282020-05-28@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1048US2031048BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AAScreening SCREENING 2020-05-282020-05-28@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BYBY mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BtBt mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 197 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1049US2031049BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BsBs mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-192021-02-19C`C` mRNA-1273-P201SVmRNA-1273-P201-US203-1050US2031050BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AAScreening SCREENING 2020-05-282020-05-28@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US203-1051US2031051BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12CC mRNA-1273-P201SVmRNA-1273-P201-US203-1052US2031052AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US203-1052US2031052A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1053US2031053AAScreening SCREENING 2020-05-282020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1054US2031054AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US203-1055US2031055AAScreening  2020-05-262020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1055US2031055A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AAScreening SCREENING 2020-05-282020-05-28@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1056US2031056BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CpCp mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1057US2031057BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AAScreening SCREENING 2020-05-282020-05-28@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1058US2031058BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1059US2031059AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B7B7 mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-162020-11-16BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1060US2031060BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1061US2031061AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B7B7 mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1062US2031062BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1063US2031063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1064US2031064AAScreening SCREENING 2020-05-292020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1064US2031064A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1065US2031065AAScreening SCREENING 2020-05-292020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US203-1065US2031065A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-132020-11-13BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1066US2031066BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1067US2031067AAScreening SCREENING 2020-05-292020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US203-1067US2031067A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1068US2031068AAScreening SCREENING 2020-05-292020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1068US2031068A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1069US2031069AAScreening SCREENING 2020-05-292020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1069US2031069A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1070US2031070AAScreening SCREENING 2020-05-292020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AAScreening SCREENING 2020-05-292020-05-29`` mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BTBT mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1071US2031071BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B3B3 mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BBBB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-232020-08-23BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-192020-11-19BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US203-1072US2031072BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-232020-08-23BSBS mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1073US2031073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-152020-06-15AACentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1074US2031074BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1075US2031075AAScreening SCREENING 2020-06-012020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US203-1076US2031076AAScreening SCREENING 2020-06-012020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US203-1077US2031077AAScreening SCREENING 2020-06-012020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US203-1078US2031078AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AAScreening SCREENING 2020-06-022020-06-02 mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-292020-08-29BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US203-1079US2031079BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03CC mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AAScreening SCREENING 2020-06-022020-06-02 mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-062020-10-06B}B}Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1080US2031080BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CPCP mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AAScreening SCREENING 2020-06-022020-06-02 mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B=B= mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-312020-08-31BYBYPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US203-1081US2031081BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1082US2031082AAScreening SCREENING 2020-06-022020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US203-1082US2031082A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1083US2031083AAScreening SCREENING 2020-06-052020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AAScreening SCREENING 2020-06-052020-06-05PP mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1084US2031084BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-062020-08-06B*B*Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1085US2031085BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-282020-12-28BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1086US2031086BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1087US2031087AAScreening SCREENING 2020-06-082020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US203-1088US2031088AAScreening SCREENING 2020-06-082020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B?B? mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1089US2031089ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1090US2031090AAScreening SCREENING 2020-06-082020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091A A(\)Screening Unscheduled 1 .SCREENING 2020-06-102020-06-10Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1091US2031091BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092A A(\)Screening Unscheduled 1 .SCREENING 2020-06-182020-06-18Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BTBT mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1092US2031092BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-042020-09-04BBBB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BWBW mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1093US2031093BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B6B6 mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1095US2031095BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1096US2031096ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B#B# mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B*B* mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02BABA mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US203-1097US2031097BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1098US2031098ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1099US2031099AAScreening SCREENING 2020-06-092020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US203-1099US2031099A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B2B2 mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B@B@ mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BSBS mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1100US2031100ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B3B3 mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01BABA mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US203-1101US2031101BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B0B0 mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-252020-09-25BVBVPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1102US2031102BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30B B mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-062020-08-06B'B'Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1103US2031103BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B2B2 mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1104US2031104ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1105US2031105ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-022020-07-02ApAp mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-072020-08-07B+B+Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B?B? mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1106US2031106BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02BBBB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1107US2031107ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B6B6 mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US203-1108US2031108ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1109US2031109ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1110US2031110ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US203-1111US2031111ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-282020-07-28B!B!Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02BEBE mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1112US2031112BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1113US2031113AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B:B: mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BSBS mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1114US2031114ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1115US2031115AAScreening SCREENING 2020-06-112020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US203-1115US2031115A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30B B mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B=B= mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-142020-10-14BlBlPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1116US2031116BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1117US2031117AAScreening SCREENING 2020-06-112020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US203-1118US2031118AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US203-1119US2031119AAScreening SCREENING 2020-06-112020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US203-1119US2031119A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1120US2031120AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B*B* mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BrBr mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-262020-10-26BwBwPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-242020-11-24BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1121US2031121BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1122US2031122ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1123US2031123AAScreening SCREENING 2020-06-172020-06-17.. mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BsBs mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1124US2031124ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AAScreening SCREENING 2020-06-192020-06-22p@ mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-132020-10-13BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-112021-01-11BBVital Signs mRNA-1273-P201SVmRNA-1273-P201-US203-1125US2031125BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1126US2031126AAScreening SCREENING 2020-06-192020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US203-1127US2031094APrevious Screening SCREENING 2020-06-092020-06-09.. mRNA-1273-P201SVmRNA-1273-P201-US203-1127US2031127A AScreening SCREENING 2020-06-222020-06-26.. mRNA-1273-P201SVmRNA-1273-P201-US203-1127US2031127A0A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B+B+ mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1128US2031128ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-132021-02-13BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AAScreening SCREENING 2020-06-252020-06-25`` mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-072020-08-07B&B&Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B;B; mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BSBS mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1129US2031129BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US203-1130US2031130AAScreening SCREENING 2020-06-252020-07-06.. mRNA-1273-P201SVmRNA-1273-P201-US203-1130US2031130A A(\)Screening Unscheduled 1 .SCREENING 2020-07-012020-07-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AAScreening SCREENING 2020-06-292020-06-2900 mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BTBT mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BnBn mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US203-1131US2031131ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US203-1132US2031132AAScreening SCREENING 2020-06-292020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US203-1133US2031133AAScreening SCREENING 2020-07-022020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US203-1134US2031134AAScreening SCREENING 2020-07-062020-07-06.. mRNA-1273-P201SVmRNA-1273-P201-US203-1135US2031135AAScreening SCREENING 2020-07-062020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US203-1136US2031136AAScreening SCREENING 2020-07-072020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1001US2041001AAScreening SCREENING 2020-05-262020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US204-1001US2041001A A(\)Screening Unscheduled 1 .SCREENING 2020-05-282020-05-28..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1002US2041002BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003BBSafety Call Day 293 CPPART A FOLLOW-UP 2021-04-012021-04-01CC mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003BBSafety Call Day 321 CPART A FOLLOW-UP 2021-04-212021-04-21C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1003US2041003BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-04-272021-04-27CC mRNA-1273-P201SVmRNA-1273-P201-US204-1004US2041004AAScreening SCREENING 2020-05-262020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-102020-07-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-132020-10-13BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US204-1005US2041005BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-082021-03-08CC mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BnBn mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1006US2041006BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007BBSafety Call Day 321 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1007US2041007BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CpCp mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BHBH mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1008US2041008BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1009US2041009AAScreening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US204-1009US2041009A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BYBY mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1010US2041010BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-172020-08-17BNBN mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1011US2041011BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B4B4 mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1012US2041012BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B0B0 mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013BBSafety Call Day 321 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1013US2041013BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CC mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-212020-07-21B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-192020-09-19BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1014US2041014BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16CC mRNA-1273-P201SVmRNA-1273-P201-US204-1015US2041015AAScreening SCREENING 2020-05-262020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1015US2041015A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BHBH mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AA(\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2020-12-142020-12-14BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016AAQPSafety Call Day 197 Unscheduled 2 .PART A FOLLOW-UP 2021-01-112021-01-11BBPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016BAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1016US2041016BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1017US2041017AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US204-1018US2041018AAScreening SCREENING 2020-05-262020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BHBH mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1019US2041019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1020US2041020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1021US2041021AAScreening SCREENING 2020-05-262020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-292020-08-29BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-052020-11-05BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-032020-12-03BBCentral Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1022US2041022BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-062020-10-06BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1023US2041023BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B7B7 mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-242020-09-24BrBrPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1024US2041024BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C C mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1025US2041025BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1026US2041026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BsBs mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-282020-09-28BxBxPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-082020-12-08BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1027US2041027BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1028US2041028AAScreening SCREENING 2020-05-272020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US204-1028US2041028A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1029US2041029BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-142020-07-14B,B,Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1030US2041030BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CpCp mRNA-1273-P201SVmRNA-1273-P201-US204-1031US2041031AAScreening SCREENING 2020-05-272020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1031US2041031A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1032US2041032AAScreening SCREENING 2020-05-272020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US204-1032US2041032A A(\)Screening Unscheduled 1 .SCREENING 2020-05-292020-05-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1033US2041033AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B B mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05BBBB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-282020-09-28BxBxPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-172021-02-17C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1034US2041034BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US204-1035US2041035AAScreening SCREENING 2020-05-272020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US204-1035US2041035A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-102020-08-10BFBFPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-192020-10-19BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1036US2041036BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1037US2041037AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US204-1038US2041038AAScreening SCREENING 2020-05-262020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US204-1039US2041039AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US204-1040US2041040AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1041US2041041BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AAScreening SCREENING 2020-05-272020-05-28P@ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-122020-12-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1042US2041042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1043US2041043AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US204-1043US2041043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1043US2041043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1044US2041044AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US204-1045US2041045AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B>B> mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-112020-08-11BEBE mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1046US2041046BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-132020-08-13BIBIPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-092020-09-09BdBdPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BsBs mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047BAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1047US2041047BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B?B? mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-01-282021-01-28BBPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1048US2041048BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-222020-07-22B1B1 mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-282020-07-28B7B7 mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BEBE mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-302020-08-30BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1049US2041049BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1050US2041050AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1051US2041051BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1052US2041052AAScreening SCREENING 2020-05-282020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US204-1052US2041052A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Physical Exam; Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B4B4 mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BFBF mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1053US2041053BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US204-1054US2041054AAScreening SCREENING 2020-05-282020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1055US2041055AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US204-1055US2041055A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1055US2041055A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1055US2041055A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-252020-06-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1055US2041055APAPVisit 4 Day 29 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B;B; mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1056US2041056BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1057US2041057AAScreening SCREENING 2020-05-282020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US204-1057US2041057A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1058US2041058AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US204-1058US2041058A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1058US2041058A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1058US2041058A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1058US2041058APAPVisit 4 Day 29 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1059US2041059AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1059US2041059A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1059US2041059A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1059US2041059A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18BNBN mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1060US2041060BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B3B3 mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-132020-08-13BIBI mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-222020-08-22BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1061US2041061BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1062US2041062BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1063US2041063AAScreening SCREENING 2020-05-282020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-0500Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064APA@Visit 3 Day 15 A .. mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1064US2041064ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1065US2041065AAScreening SCREENING 2020-05-282020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1066US2041066AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1066US2041066A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1067US2041067AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1067US2041067A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1068US2041068AAScreening SCREENING 2020-05-282020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1069US2041069AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1070US2041070AAScreening SCREENING 2020-05-292020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US204-1070US2041070A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BCBC mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1071US2041071BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US204-1072US2041072AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-052020-10-05B~B~Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1073US2041073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1074US2041074AAScreening SCREENING 2020-05-292020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075AASafety Call Day 237 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1075US2041075BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05BABA mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-132020-08-13BIBIPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1076US2041076BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B7B7 mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US204-1077US2041077BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B;B; mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1078US2041078BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-222021-03-22CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B4B4 mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BBBB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BWBW mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1079US2041079BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CPCP mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-052021-01-05BBPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-082021-02-08BBCentral Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US204-1080US2041080BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1081US2041081AAScreening SCREENING 2020-06-012020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1081US2041081A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1082US2041082AAScreening SCREENING 2020-06-012020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US204-1083US2041083AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B?B? mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-092020-09-09BbBbPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1084US2041084BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1085US2041085AAScreening SCREENING 2020-06-042020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1085US2041085A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-292020-10-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1086US2041086AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1087US2041087AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1087US2041087A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-142020-09-14BcBcPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-292020-09-29BrBrPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-292020-10-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1088US2041088BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1089US2041089BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BnBn mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-252020-09-25BnBnPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1090US2041090BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AAScreening SCREENING 2020-06-052020-06-05PP mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24AA mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B0B0 mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B>B> mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-252020-09-25BlBlPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-292020-10-29BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091BASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1091US2041091BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-012021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US204-1092US2041092BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1093US2041093AAScreening SCREENING 2020-06-082020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AAScreening SCREENING 2020-06-082020-06-08 mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-202020-08-20B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1094US2041094ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1095US2041095AAScreening SCREENING 2020-06-092020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US204-1095US2041095A A(\)Screening Unscheduled 1 .SCREENING 2020-06-152020-06-15..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BsBs mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1096US2041096ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1097US2041097AAScreening SCREENING 2020-06-092020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1098US2041098AAScreening SCREENING 2020-06-092020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US204-1099US2041099AAScreening SCREENING 2020-06-092020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BWBW mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1100US2041100BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1101US2041101AAScreening SCREENING 2020-06-102020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US204-1101US2041101A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1102US2041102ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1103US2041103BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1104US2041104ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1105US2041105AAScreening SCREENING 2020-06-102020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US204-1105US2041105A A Visit 1 Day 1 ASCREENING 2020-06-292020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1105US2041105A0A (\(Visit 1 Day 1 Unscheduled 1 .SCREENING 2020-06-292020-06-29..Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Pregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AAScreening SCREENING 2020-06-112020-06-26A mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1106US2041106BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1107US2041107BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-142020-09-14BQBQCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-122020-12-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1108US2041108BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1109US2041109ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1110US2041110AAScreening SCREENING 2020-06-112020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US204-1110US2041110A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1111US2041111BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01BDBD mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1112US2041112ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-172020-09-17BPBPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08BeBe mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-162020-10-16BmBmPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-032020-12-03BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113BASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1113US2041113BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01BDBD mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1114US2041114ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04B#B# mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B1B1 mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B>B> mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-052020-10-05BaBaPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1115US2041115ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-04-132021-04-13CC mRNA-1273-P201SVmRNA-1273-P201-US204-1116US2041116AAScreening SCREENING 2020-06-112020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1116US2041116A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1117US2041117ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1118US2041118ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-142020-09-14BGBGVital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B_B_ mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1119US2041119BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B*B* mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1120US2041120ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AASafety Call Day 113 Bq .. mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1121US2041121ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BWBW mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1122US2041122BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-312020-07-31B$B$Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-182020-09-18BUBUCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1123US2041123BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1124US2041124AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AASafety Call Day 113 Bq .. mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1125US2041125BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1126US2041126BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-162020-09-16BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1127US2041127BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-112021-03-11C0C0 mRNA-1273-P201SVmRNA-1273-P201-US204-1128US2041128AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US204-1129US2041129AAScreening SCREENING 2020-06-152020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US204-1129US2041129A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1130US2041130BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-172020-08-17B2B2 mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-152020-09-15BOBO mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1131US2041131BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-142020-11-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1132US2041132BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1133US2041133AAScreening SCREENING 2020-06-152020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US204-1133US2041133A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1134US2041134AAScreening SCREENING 2020-06-152020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US204-1134US2041134A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1135US2041135AAScreening SCREENING 2020-06-152020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B"B" mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B)B) mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B1B1 mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B?B? mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BWBW mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-162021-01-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1136US2041136BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1137US2041137AAScreening SCREENING 2020-06-152020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-162020-09-16BSBS mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1138US2041138BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BVBV mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139BBSafety Call Day 293 CP .. mRNA-1273-P201SVmRNA-1273-P201-US204-1139US2041139BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1140US2041140AAScreening SCREENING 2020-06-162020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1140US2041140A A(\)Screening Unscheduled 1 .SCREENING 2020-06-292020-06-29..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1141US2041141AAScreening SCREENING 2020-06-162020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1141US2041141A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-262020-09-26BWBW mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BuBu mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-162021-01-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1142US2041142BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1143US2041143AAScreening SCREENING 2020-06-162020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1144US2041144BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08BcBc mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AASafety Call Day 169 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-162021-01-16BB mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1145US2041145BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B8B8 mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08BcBc mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1146US2041146BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1147US2041147AAScreening SCREENING 2020-06-172020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1147US2041147A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1148US2041148AAScreening SCREENING 2020-06-172020-06-17.. mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B;B; mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B_B_ mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1149US2041149BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B"B" mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B3B3 mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B@B@ mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-262020-09-26BXBX mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-242020-10-24BtBt mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150ABSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1150US2041150BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B:B: mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B_B_ mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151BBSafety Call Day 265 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1151US2041151BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21AA mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B&B& mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B-B- mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B;B; mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B^B^ mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US204-1152US2041152BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US204-1153US2041153AAScreening SCREENING 2020-06-232020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1154US2041154AAScreening SCREENING 2020-06-252020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AAScreening SCREENING 2020-06-292020-06-29pp mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B_B_ mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1155US2041155BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1156US2041156AAScreening SCREENING 2020-06-292020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US204-1157US2041157AAScreening SCREENING 2020-06-292020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1158US2041158AAScreening SCREENING 2020-06-302020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1159US2041159AAScreening SCREENING 2020-06-302020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US204-1160US2041160AAScreening SCREENING 2020-06-302020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1161US2041161AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1162US2041162AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1163US2041163AAScreening SCREENING 2020-07-012020-07-01.. mRNA-1273-P201SVmRNA-1273-P201-US204-1164US2041164AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1165US2041165AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AAScreening SCREENING 2020-07-012020-07-01PP mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AASafety Call Day 85 BUPART A FOLLOW-UP 2020-10-082020-10-08B_B_ mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BrBr mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AASafety Call Day 141 B .. mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166ABSafety Call Day 321 C .. mRNA-1273-P201SVmRNA-1273-P201-US204-1166US2041166BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US204-1167US2041167AAScreening SCREENING 2020-07-012020-07-07.. mRNA-1273-P201SVmRNA-1273-P201-US204-1168US2041168AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1169US2041169AAScreening SCREENING 2020-07-022020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1170US2041170AAScreening SCREENING 2020-07-072020-07-07.. mRNA-1273-P201SVmRNA-1273-P201-US204-1171US2041171AAScreening SCREENING 2020-07-072020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US204-1172US2041172AAScreening SCREENING 2020-07-072020-07-07.. mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-282021-01-11BBLocal Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1001US2051001BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C@C@ mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AAScreening SCREENING 2020-05-262020-05-26pp mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1002US2051002BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-06-302020-06-30B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-102020-07-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B=B= mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-182020-08-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-152020-09-15BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1003US2051003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1004US2051004AAScreening SCREENING 2020-05-262020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US205-1004US2051004A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1005US2051005AAScreening SCREENING 2020-05-262020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US205-1005US2051005A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1006US2051006AAScreening SCREENING 2020-05-262020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US205-1006US2051006A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1007US2051007AAScreening SCREENING 2020-05-262020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US205-1007US2051007A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-182020-08-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-162020-09-16BoBo mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-132020-10-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1008US2051008BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12C@C@ mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1009US2051009BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-022020-10-02B{B{Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1010US2051010BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1011US2051011BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AAScreening SCREENING 2020-05-272020-05-27`` mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1012US2051012BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1013US2051013AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1014US2051014AAScreening SCREENING 2020-05-272020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1014US2051014A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1015US2051015AAScreening SCREENING 2020-05-272020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US205-1015US2051015A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1016US2051016AAScreening SCREENING 2020-05-272020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1016US2051016A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-0200Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B7B7 mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1017US2051017BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1018US2051018BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B?B? mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BrBr mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-302020-11-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1019US2051019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B=B= mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1020US2051020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-012021-03-01CC mRNA-1273-P201SVmRNA-1273-P201-US205-1021US2051021AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US205-1021US2051021A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1022US2051022BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US205-1023US2051023AAScreening SCREENING 2020-05-282020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US205-1023US2051023A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AAScreening SCREENING 2020-05-272020-05-28`P mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1024US2051024BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B#B# mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1025US2051025BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16CC mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B@B@ mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1026US2051026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B6B6 mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1027US2051027BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18CC mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028APAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028A`AP(\(Visit 4 Day 29 Unscheduled 1 .PART A FOLLOW-UP 2020-07-022020-07-02BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028ApA`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B6B6 mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1028US2051028BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CPCP mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-292020-10-29BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1029US2051029BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B?B? mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-08-312020-08-31BZBZCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-102020-12-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1030US2051030BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1031US2051031BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-012020-07-01BBPregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1032US2051032BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C@C@ mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-102020-07-10B%B%Physical Exam; Vital Signs; Pregnancy Test; Local Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B7B7 mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033AA(\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2020-12-082020-12-08BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1033US2051033BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C C mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034A@A0(\(Visit 2 Day 8 Unscheduled 1 .BLINDED TREATMENT 2020-06-102020-06-10AACentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1034US2051034BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B#B# mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-032020-09-03B\B\Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-022020-10-02ByByPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1035US2051035BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BtBt mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1036US2051036BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C`C` mRNA-1273-P201SVmRNA-1273-P201-US205-1037US2051037AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US205-1038US2051038AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US205-1038US2051038A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1038US2051038A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1038US2051038A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1038US2051038APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1039US2051039AAScreening SCREENING 2020-05-292020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US205-1039US2051039A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AAScreening SCREENING 2020-05-292020-05-29pp mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040A`A@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-222020-06-22BBPhysical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040ApAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1040US2051040BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1041US2051041AAScreening SCREENING 2020-05-292020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-292020-12-29BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1042US2051042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B7B7 mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BSBS mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-162020-10-16BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1043US2051043BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16C0C0 mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B6B6 mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1044US2051044BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AAScreening SCREENING 2020-06-032020-06-03pp mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24AA mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BVBV mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-252020-11-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1045US2051045BBParticipant Decision Visit / OL-D1. .. mRNA-1273-P201SVmRNA-1273-P201-US205-1046US2051046AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US205-1047US2051047AAScreening SCREENING 2020-06-032020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1047US2051047A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AAScreening SCREENING 2020-06-032020-06-03`` mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-252020-06-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B B mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B1B1 mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-122020-12-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1048US2051048BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1049US2051049AAScreening SCREENING 2020-06-042020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1049US2051049A A(\)Screening Unscheduled 1 .SCREENING 2020-06-092020-06-09..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AAScreening SCREENING 2020-06-042020-06-04@@ mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1050US2051050BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-222021-02-22C@C@ mRNA-1273-P201SVmRNA-1273-P201-US205-1051US2051051AAScreening SCREENING 2020-06-092020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1052US2051052AAScreening SCREENING 2020-06-092020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1053US2051053AAScreening SCREENING 2020-06-102020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BXBX mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-242020-12-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1054US2051054ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30B#B# mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1055US2051055ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1056US2051056AAScreening SCREENING 2020-06-122020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-312020-07-31B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1057US2051057ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1058US2051058AAScreening SCREENING 2020-06-152020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US205-1058US2051058A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1059US2051059ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-132020-10-13BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-102020-11-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AA(\(Safety Call Day 197 Unscheduled 1 .PART A FOLLOW-UP 2020-12-282020-12-28BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1060US2051060BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1061US2051061AAScreening SCREENING 2020-06-162020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US205-1061US2051061A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1062US2051062AAScreening SCREENING 2020-06-162020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-102020-12-10BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-182021-01-18BBCentral Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1063US2051063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BVBV mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1064US2051064ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1065US2051065AAScreening SCREENING 2020-06-172020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US205-1065US2051065A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B6B6 mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1066US2051066ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1067US2051067AAScreening SCREENING 2020-06-172020-06-17.. mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-112020-08-11B+B+Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1068US2051068BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-152020-09-15BRBR mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-132020-10-13BnBn mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1069US2051069ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B"B" mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1070US2051070ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1071US2051071ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-232020-09-21B1BNCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Local Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-212020-09-21BNBN mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1072US2051072BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-052020-08-05BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-312020-12-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1073US2051073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1074US2051074ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BTBT mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BpBp mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1075US2051075AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1076US2051076AAScreening SCREENING 2020-06-192020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1077US2051077ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1078US2051078ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1079US2051079AAScreening SCREENING 2020-06-222020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US205-1080US2051080AAScreening SCREENING 2020-06-222020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US205-1080US2051080A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AAScreening SCREENING 2020-06-232020-06-23`` mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BrBr mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1081US2051081ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1082US2051082AAScreening SCREENING 2020-06-232020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US205-1082US2051082A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1083US2051083AAScreening SCREENING 2020-06-232020-07-01.. mRNA-1273-P201SVmRNA-1273-P201-US205-1083US2051083A A(\)Screening Unscheduled 1 .SCREENING 2020-07-012020-07-01..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B@B@ mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1084US2051084ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B>B> mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1085US2051085ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1086US2051086ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AAScreening SCREENING 2020-06-252020-06-25 mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087A A(\)Screening Unscheduled 1 .SCREENING 2020-06-292020-06-29ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BABA mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1087US2051087BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AAScreening SCREENING 2020-06-252020-06-25PP mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1088US2051088ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AAScreening SCREENING 2020-06-252020-06-26p` mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1089US2051089ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1090US2051090AAScreening SCREENING 2020-06-252020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US205-1091US2051091AAScreening SCREENING 2020-06-262020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US205-1091US2051091A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AAScreening SCREENING 2020-06-262020-06-26 mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092A A(\)Screening Unscheduled 1 .SCREENING 2020-07-012020-07-01``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21AA mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06BB mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-082020-12-08BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1092US2051092BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AAScreening SCREENING 2020-06-262020-06-26 mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-012020-10-01BXBXPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-092020-11-09BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093BASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1093US2051093BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AAScreening SCREENING 2020-06-292020-06-29 mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-272020-10-27BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1094US2051094BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AAScreening SCREENING 2020-06-292020-06-2900 mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B*B* mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B8B8 mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1095US2051095ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AAScreening SCREENING 2020-06-292020-06-29pp mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1096US2051096BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AAScreening SCREENING 2020-06-292020-06-29pp mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1097US2051097ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AAScreening SCREENING 2020-06-292020-06-29pp mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-052020-08-05BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BABA mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US205-1098US2051098ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AAScreening SCREENING 2020-06-292020-06-29pp mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1099US2051099ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AAScreening SCREENING 2020-06-292020-06-2900 mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04B"B" mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B)B) mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B0B0 mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BEBE mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1100US2051100ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-262020-08-26B4B4 mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-102020-09-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BVBV mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-302020-11-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US205-1101US2051101ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AAScreening SCREENING 2020-06-302020-07-01`P mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1102US2051102ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AAScreening SCREENING 2020-06-302020-06-30 mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16AA mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1103US2051103ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1104US2051104AAScreening SCREENING 2020-06-302020-06-30pp mRNA-1273-P201SVmRNA-1273-P201-US205-1104US2051104A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US205-1104US2051104A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-172020-07-17AA mRNA-1273-P201SVmRNA-1273-P201-US205-1104US2051104A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AAScreening SCREENING 2020-06-302020-06-30 mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-302020-09-30B[B[Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-042020-12-04BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US205-1105US2051105BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US205-1106US2051106ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AAScreening SCREENING 2020-06-302020-06-30 mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-272021-01-27BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1107US2051107BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-252020-08-25B3B3 mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BABA mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-112020-11-11BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US205-1108US2051108BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-162021-02-16BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B&B& mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B;B; mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-292020-09-29BVBV mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US205-1109US2051109ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-182021-02-18BB mRNA-1273-P201SVmRNA-1273-P201-US205-1110US2051110AAScreening SCREENING 2020-07-012020-07-01.. mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AAScreening SCREENING 2020-07-012020-07-01PP mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-242020-08-24B2B2 mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US205-1111US2051111ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AAScreening SCREENING 2020-07-012020-07-01PP mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20AA mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US205-1112US2051112ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02 Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B6B6 mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B>B> mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1001US2061001BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1002US2061002AAScreening SCREENING 2020-05-282020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US206-1002US2061002A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02 Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B!B! mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B(B( mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B=B= mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1003US2061003BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-252021-02-25CC mRNA-1273-P201SVmRNA-1273-P201-US206-1004US2061004AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US206-1004US2061004A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1005US2061005AAScreening SCREENING 2020-05-282020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1006US2061006BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1007US2061007AAScreening SCREENING 2020-05-282020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B0B0 mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1008US2061008BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B?B? mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-072020-10-07BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1009US2061009BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B?B? mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1010US2061010BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BEBE mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-252020-09-25BsBsPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1011US2061011BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1012US2061012AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US206-1012US2061012A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01@@Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B=B= mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-292020-12-29BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1013US2061013BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1014US2061014AAScreening SCREENING 2020-05-282020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US206-1014US2061014A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015A@A0(\(Visit 2 Day 8 Unscheduled 1 .BLINDED TREATMENT 2020-06-112020-06-11AAVital Signs mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B3B3 mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1015US2061015BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1016US2061016AAScreening SCREENING 2020-05-292020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US206-1016US2061016A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1017US2061017AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AAScreening SCREENING 2020-05-292020-05-29pp mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BEBE mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-012020-12-01BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-302020-12-30BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1018US2061018BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B0B0 mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-292020-07-29B9B9 mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-232020-09-23BqBqPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1019US2061019BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AAScreening SCREENING 2020-05-292020-05-29 mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-0500Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-022020-10-02BuBu mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-252020-11-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US206-1020US2061020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AAScreening SCREENING 2020-05-292020-05-29`` mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-0100Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B%B% mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-302020-07-30B9B9 mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1021US2061021BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B8B8 mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1022US2061022BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AAScreening SCREENING 2020-05-292020-05-29pp mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023A0A (\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-112020-06-11ApApVital Signs mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-072020-10-07B}B}Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1023US2061023BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B?B? mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-302020-11-30BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1024US2061024BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AAScreening SCREENING 2020-05-292020-05-29PP mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B;B; mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US206-1025US2061025BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B=B= mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-162020-09-16BhBhPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1026US2061026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-102021-02-10BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B?B? mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1027US2061027BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1028US2061028AAScreening SCREENING 2020-06-022020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US206-1028US2061028A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1029US2061029AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US206-1029US2061029A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1030US2061030AAScreening SCREENING 2020-06-032020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US206-1031US2061031AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US206-1032US2061032BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-092021-02-09BB mRNA-1273-P201SVmRNA-1273-P201-US206-1033US2061033AAScreening SCREENING 2020-06-032020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US206-1033US2061033A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1034US2061034AAScreening SCREENING 2020-06-052020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US206-1034US2061034A A(\)Screening Unscheduled 1 .SCREENING 2020-06-082020-06-08..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18B6B6 mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-162020-09-16BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBPhysical Exam; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1035US2061035BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-162020-09-16BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-142020-10-14BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-112020-11-11BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-142020-11-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1036US2061036BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AAScreening SCREENING 2020-06-092020-06-09 mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-192020-09-19BVBV mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US206-1037US2061037ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US206-1038US2061038AAScreening SCREENING 2020-06-092020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US206-1038US2061038A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1039US2061039AAScreening SCREENING 2020-06-102020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US206-1040US2061040AAScreening SCREENING 2020-06-102020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US206-1040US2061040A A(\)Screening Unscheduled 1 .SCREENING 2020-06-152020-06-15..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1041US2061041AAScreening SCREENING 2020-06-102020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US206-1041US2061041A A(\)Screening Unscheduled 1 .SCREENING 2020-06-152020-06-15..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1042US2061042AAScreening SCREENING 2020-06-102020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US206-1042US2061042A A(\)Screening Unscheduled 1 .SCREENING 2020-06-162020-06-16..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B6B6 mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-192020-09-19BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1043US2061043ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1044US2061044AAScreening SCREENING 2020-06-102020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US206-1044US2061044A A(\)Screening Unscheduled 1 .SCREENING 2020-06-152020-06-15..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AAScreening SCREENING 2020-06-102020-06-10 mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B,B, mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-202020-08-20B5B5 mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-192020-09-19BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1045US2061045ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-192020-09-19BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BnBn mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-152020-12-15BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-152021-01-15BBPhysical Exam; Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1046US2061046BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1047US2061047AAScreening SCREENING 2020-06-112020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US206-1047US2061047A A(\)Screening Unscheduled 1 .SCREENING 2020-06-182020-06-18..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1048US2061048AAScreening SCREENING 2020-06-112020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US206-1048US2061048A A(\)Screening Unscheduled 1 .SCREENING 2020-06-172020-06-17..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1049US2061049AAScreening SCREENING 2020-06-112020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US206-1049US2061049A A(\)Screening Unscheduled 1 .SCREENING 2020-06-182020-06-18..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1050US2061050AAScreening SCREENING 2020-06-152020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US206-1050US2061050A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30BB mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BXBX mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BrBr mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1051US2061051ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1052US2061052AAScreening SCREENING 2020-06-152020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US206-1052US2061052A A(\)Screening Unscheduled 1 .SCREENING 2020-06-182020-06-18..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B7B7 mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BSBS mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US206-1053US2061053ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1054US2061054AAScreening SCREENING 2020-06-162020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US206-1054US2061054A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BWBW mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US206-1055US2061055ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US206-1056US2061056AAScreening SCREENING 2020-06-162020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US206-1056US2061056A A(\)Screening Unscheduled 1 .SCREENING 2020-06-192020-06-19..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B7B7 mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BTBT mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1057US2061057BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1058US2061058AAScreening SCREENING 2020-06-182020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US206-1059US2061059AAScreening SCREENING 2020-06-182020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US206-1059US2061059A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1060US2061060AAScreening SCREENING 2020-06-192020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US206-1060US2061060A A(\)Screening Unscheduled 1 .SCREENING 2020-06-222020-06-22..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1061US2061061AAScreening SCREENING 2020-06-192020-06-26.. mRNA-1273-P201SVmRNA-1273-P201-US206-1061US2061061A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1062US2061062AAScreening SCREENING 2020-06-192020-06-26.. mRNA-1273-P201SVmRNA-1273-P201-US206-1062US2061062A A(\)Screening Unscheduled 1 .SCREENING 2020-06-232020-06-23..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063A A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24``Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B$B$ mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AApVisit 6 Day 43 B+ .. mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B?B? mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BXBX mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1063US2061063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-112021-02-11BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B8B8 mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BWBW mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US206-1064US2061064ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US206-1065US2061065AAScreening SCREENING 2020-06-232020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US206-1065US2061065A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1066US2061066AAScreening SCREENING 2020-06-232020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US206-1067US2061067AAScreening SCREENING 2020-06-232020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US206-1067US2061067A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AAScreening SCREENING 2020-06-242020-06-24`` mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26@@Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31B B mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AApVisit 6 Day 43 B+ .. mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02BABA mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BWBW mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US206-1068US2061068BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US206-1069US2061069AAScreening SCREENING 2020-06-242020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US206-1070US2061070AAScreening SCREENING 2020-06-292020-07-06.. mRNA-1273-P201SVmRNA-1273-P201-US206-1070US2061070A A(\)Screening Unscheduled 1 .SCREENING 2020-07-022020-07-02..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US206-1071US2061071AAScreening SCREENING 2020-06-302020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US206-1072US2061072AAScreening SCREENING 2020-07-012020-07-08.. mRNA-1273-P201SVmRNA-1273-P201-US206-1072US2061072A A(\)Screening Unscheduled 1 .SCREENING 2020-07-062020-07-06..Vital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AAScreening SCREENING 2020-05-222020-05-22pp mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28B\B\ mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-162020-09-16BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-152020-10-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-282020-10-28BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-112020-11-11BB mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1001US2071001BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BC mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AAScreening SCREENING 2020-05-222020-05-22 mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-092020-07-09B'B'Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1002US2071002BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AAScreening SCREENING 2020-05-222020-05-22 mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-182020-09-18BnBn mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-302020-11-30BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1003US2071003BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B1B1 mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-142020-10-14BBPhysical Exam; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-122020-11-12BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1004US2071004BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B1B1 mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01B\B\ mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-252020-11-25BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AAQPSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-282020-12-28BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US207-1005US2071005BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B8B8 mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1006US2071006BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BC mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-032020-11-03BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1007US2071007BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-23BC mRNA-1273-P201SVmRNA-1273-P201-US207-1008US2071008AAScreening SCREENING 2020-05-252020-05-25.. mRNA-1273-P201SVmRNA-1273-P201-US207-1009US2071009AAScreening SCREENING 2020-05-252020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1009US2071009A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1010US2071010AAScreening SCREENING 2020-05-252020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1011US2071011AAScreening SCREENING 2020-05-252020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US207-1011US2071011A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-042020-12-04BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1012US2071012BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B?B? mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B^B^ mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-172020-11-17BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1013US2071013BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BC mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B?B? mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BZBZ mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1014US2071014BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-24BC mRNA-1273-P201SVmRNA-1273-P201-US207-1015US2071015AAScreening SCREENING 2020-05-252020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US207-1015US2071015A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1016US2071016BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AAScreening SCREENING 2020-05-252020-05-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-182020-08-18BNBN mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BrBr mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-112020-11-11BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1017US2071017BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1018US2071018AAScreening SCREENING 2020-05-252020-05-25.. mRNA-1273-P201SVmRNA-1273-P201-US207-1019US2071019AAScreening SCREENING 2020-05-252020-05-25.. mRNA-1273-P201SVmRNA-1273-P201-US207-1020US2071020AAScreening SCREENING 2020-05-252020-05-25.. mRNA-1273-P201SVmRNA-1273-P201-US207-1021US2071021AAScreening SCREENING 2020-05-252020-05-25.. mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BABA mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-172020-11-17BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1022US2071022BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1023US2071023AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1024US2071024BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-042021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-232020-10-23BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1025US2071025BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-23BC mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-302020-07-30B5B5 mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BBBB mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-082020-09-08B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1026US2071026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BCp mRNA-1273-P201SVmRNA-1273-P201-US207-1027US2071027AAScreening SCREENING 2020-05-262020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1028US2071028AAScreening SCREENING 2020-05-262020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US207-1028US2071028A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B5B5 mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1029US2071029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AAScreening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BFBF mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1030US2071030BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BC mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-122020-08-12BBBB mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CpCp mRNA-1273-P201SVmRNA-1273-P201-US207-1032US2071032BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-052021-03-05CC mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-132020-08-13BCBC mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1033US2071033BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BCp mRNA-1273-P201SVmRNA-1273-P201-US207-1034US2071034AAScreening SCREENING 2020-05-272020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US207-1035US2071035AAScreening SCREENING 2020-05-272020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-02``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-292020-07-29B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BABA mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-082020-09-08B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-282020-10-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CpCp mRNA-1273-P201SVmRNA-1273-P201-US207-1036US2071036BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-092021-03-09C0C0 mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AAScreening SCREENING 2020-05-272020-05-27pp mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BZBZ mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1037US2071037BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-23BC mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-292020-07-29B8B8 mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BEBE mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-042020-09-04B]B] mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BrBr mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-012020-12-01BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1038US2071038BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-03BC mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AAScreening SCREENING 2020-05-272020-05-27 mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-302020-07-30B8B8 mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-132020-08-13BFBF mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-132020-08-13BFBFCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-082020-09-08B`B` mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1039US2071039BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-24BC mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040A A(\)Screening Unscheduled 1 .SCREENING 2020-06-012020-06-01ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-282020-07-28B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-092020-09-09B^B^ mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1040US2071040BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-23BCP mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-102020-07-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-092020-10-09BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-062020-11-06BBPhysical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1041US2071041BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BABA mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BrBr mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1042US2071042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1043US2071043BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BC mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AAScreening SCREENING 2020-05-282020-05-28 mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1044US2071044BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1045US2071045AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AAScreening SCREENING 2020-05-282020-05-28pp mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BEBE mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-302020-12-30BB mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1046US2071046BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-05BC0 mRNA-1273-P201SVmRNA-1273-P201-US207-1048US2071048AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AAScreening SCREENING 2020-05-292020-05-29`` mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1049US2071049BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AAScreening SCREENING 2020-05-292020-05-29pp mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050A A(\)Screening Unscheduled 1 .SCREENING 2020-06-022020-06-0200Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1050US2071050BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AAScreening SCREENING 2020-05-292020-05-29pp mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051A A(\)Screening Unscheduled 1 .SCREENING 2020-06-032020-06-03 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-112020-12-11BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-302020-12-30BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051BAQPVisit 8 Day 209 Unscheduled 2 .PART A FOLLOW-UP 2021-01-132021-01-13BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1051US2071051BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BC mRNA-1273-P201SVmRNA-1273-P201-US207-1053US2071053AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US207-1054US2071054AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US207-1055US2071055AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US207-1056US2071056AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US207-1058US2071058AAScreening SCREENING 2020-06-012020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US207-1058US2071058A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AAScreening SCREENING 2020-06-012020-06-01pp mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1059US2071059BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-05BC mRNA-1273-P201SVmRNA-1273-P201-US207-1060US2071060AAScreening SCREENING 2020-06-012020-06-10.. mRNA-1273-P201SVmRNA-1273-P201-US207-1061US2071061AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BZBZ mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-192020-11-19BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1062US2071062BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BC mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1063US2071063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AAScreening SCREENING 2020-06-012020-06-01@@ mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BXBX mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1064US2071064BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-19BC mRNA-1273-P201SVmRNA-1273-P201-US207-1065US2071065AAScreening SCREENING 2020-06-012020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AAScreening SCREENING 2020-06-012020-06-01 mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-05@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B8B8 mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1066US2071066BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-02BC mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AAScreening SCREENING 2020-06-012020-06-01@@ mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-132020-08-13BFBF mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1067US2071067BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-10BCp mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AAScreening SCREENING 2020-06-012020-06-01pp mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068A A(\)Screening Unscheduled 1 .SCREENING 2020-06-052020-06-0500Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-012020-10-01BtBt mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-102020-11-10BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1068US2071068BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-282020-07-28B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-172020-08-17BGBG mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-042020-09-04BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-292020-10-29BB mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1069US2071069BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BCp mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-222020-12-22BBCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1070US2071070BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BDBD mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03B[B[ mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BtBt mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-232020-11-23BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1071US2071071BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B B mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B'B' mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-312020-07-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-182020-11-18BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AAQPSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-042020-12-04BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072BAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1072US2071072BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BrBr mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1073US2071073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BC mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-042020-09-04BYBY mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-092020-12-09BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CpCp mRNA-1273-P201SVmRNA-1273-P201-US207-1074US2071074BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US207-1075US2071075AAScreening SCREENING 2020-06-022020-06-08.. mRNA-1273-P201SVmRNA-1273-P201-US207-1076US2071076AAScreening SCREENING 2020-06-032020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AAScreening SCREENING 2020-06-032020-06-03PP mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-102020-07-10B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-042020-08-04B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-232020-11-23BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1077US2071077BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-252021-02-25CpCp mRNA-1273-P201SVmRNA-1273-P201-US207-1078US2071078AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US207-1079US2071079AAScreening SCREENING 2020-06-042020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US207-1080US2071080AAScreening SCREENING 2020-06-052020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07BB mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1081US2071081BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BC mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US207-1082US2071082ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071057APrevious Screening SCREENING 2020-05-262020-05-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083A AScreening SCREENING 2020-06-152020-06-26A mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-062020-08-06B*B*Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1083US2071083BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AAScreening SCREENING 2020-06-052020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-282020-07-28B!B!PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BtBt mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1084US2071084BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1085US2071085ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086A0A0Visit 2 Day 8 A .. mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086A@A@Visit 3 Day 15 A .. mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-102020-11-10BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1086US2071086BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-302020-07-30B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B@B@ mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-022020-09-02BEBECentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-292020-09-29B`B`Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1087US2071087BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071052APrevious Screening SCREENING 2020-05-292020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B0B0 mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1088US2071088BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071031APrevious Screening SCREENING 2020-05-262020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089A AScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B1B1 mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B?B? mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-202020-10-20BuBuVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1089US2071089BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-012020-09-01BABACentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1090US2071090BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AAScreening SCREENING 2020-06-192020-06-19pp mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-272020-07-27B B mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-072020-08-07B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-252020-08-25B=B=Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-10-202020-10-20BuBuVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-222020-12-22BBCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091BASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1091US2071091BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AAScreening SCREENING 2020-06-192020-06-19pp mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-282020-07-28B!B! mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-052020-08-05B)B) mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-192020-08-19B7B7 mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-172020-09-17BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-152020-10-15BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-122020-11-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-162020-11-16BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-092020-12-09BB mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-162020-12-16BBPhysical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US207-1092US2071092BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AAScreening SCREENING 2020-06-222020-06-22pp mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25@@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B(B( mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01BABA mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1093US2071093BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-042020-09-04B=B=Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-302020-09-30BWBW mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBCentral Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094BASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1094US2071094BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AAScreening SCREENING 2020-06-232020-06-23`` mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B+B+ mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B:B: mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-082021-01-08BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1095US2071095BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071047APrevious Screening SCREENING 2020-05-282020-06-19# mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096A AScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096A0A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096A@A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096APA0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096A`A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096ApA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-212020-07-21BBCentral Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-052020-08-05B#B# mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-212020-08-21B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-042020-09-04BABA mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-162020-09-16BMBMCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096BASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096BASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1096US2071096BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US207-1097US2071097AAScreening SCREENING 2020-06-242020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AAScreening SCREENING 2020-06-242020-06-24pp mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B2B2 mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B>B> mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BoBo mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-102020-11-10BBVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US207-1098US2071098BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-152020-07-15AA mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21AA mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B*B* mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-262020-08-26B3B3Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B;B; mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-09-102020-09-10BBBBCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-082020-10-08B^B^Physical Exam; Vital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AAQPSafety Call Day 85 Unscheduled 2 .PART A FOLLOW-UP 2020-10-092020-10-09B_B_Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099BASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099BASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099BASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1099US2071099BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AAScreening SCREENING 2020-06-252020-06-25 mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-222020-07-22BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-042020-08-04BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-08-262020-08-26B4B4Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03B<B< mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US207-1100US2071100BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-01BB mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101AAScreening SCREENING 2020-06-252020-06-25@@ mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1101US2071101A`A`Visit 5 Day 36 B$ .. mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AAScreening SCREENING 2020-06-252020-06-25@@ mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-282020-07-28BB mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-042020-08-04B%B% mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US207-1102US2071102ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AAScreening SCREENING 2020-06-262020-07-02`A mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-102020-07-10AA mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-212020-08-21B3B3 mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-112020-09-11BHBH mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BTBT mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-092020-10-09BdBdVital Signs; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BpBp mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-042021-01-04BBVital Signs; Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1103US2071103BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AAScreening SCREENING 2020-06-262020-06-26 mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-262020-08-26B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-042020-09-04B=B= mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-292020-09-29BVBVPhysical Exam; Vital Signs; Central Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1104US2071104BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AAScreening SCREENING 2020-06-302020-06-30`` mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-262020-08-26B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-092020-09-09BBBB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US207-1105US2071105ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-01-292021-02-01BB mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AAScreening SCREENING 2020-07-012020-07-01PP mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106A0A0Visit 2 Day 8 APART A FOLLOW-UP 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106A@A0(\(Visit 2 Day 8 Unscheduled 1 .PART A FOLLOW-UP 2020-07-152020-07-15AALocal Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106APA0QRVisit 2 Day 8 Unscheduled 2 .PART A FOLLOW-UP 2020-08-132020-08-13B'B'Physical Exam; Vital Signs; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106A`A@Visit 3 Day 15 A .. mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106ApAPVisit 4 Day 29 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AA`Visit 5 Day 36 B$ .. mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B4B4 mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106AASafety Call Day 197 B .. mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US207-1106US2071106BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-012020-07-01B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-082020-07-08B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-232020-07-23B8B8 mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-112020-08-11BKBKCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-202020-08-20BTBT mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-032021-02-03BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1001US2081001BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-252020-06-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-022020-07-02B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-092020-07-09B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-242020-07-24B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-162020-10-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-082020-12-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1002US2081002BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-132020-07-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1003US2081003BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15CpCp mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AAScreening SCREENING 2020-05-262020-05-2600 mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004A A Visit 1 Day 1 ABLINDED TREATMENT 2020-05-292020-05-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29B B mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-012020-07-01B"B"Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-212020-08-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BtBt mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-142020-10-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1004US2081004BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AAScreening SCREENING 2020-05-262020-05-26`` mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-172020-07-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-082021-01-08BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1005US2081005BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C@C@ mRNA-1273-P201SVmRNA-1273-P201-US208-1006US2081006AAScreening SCREENING 2020-05-262020-05-26.. mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AAp(\(Visit 6 Day 43 Unscheduled 1 .BLINDED TREATMENT 2020-07-212020-07-21B3B3Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1007US2081007AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1008US2081008AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-022020-07-02B B mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1009US2081009BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1010US2081010AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US208-1011US2081011AAScreening SCREENING 2020-05-272020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US208-1012US2081012AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US208-1013US2081013AAScreening SCREENING 2020-05-272020-05-27.. mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-062020-07-06B$B$Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1014US2081014BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-092020-07-09B'B'Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-272020-07-27B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1015US2081015BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AAScreening SCREENING 2020-05-272020-05-27PP mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-012020-06-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-142020-07-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BYBY mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-212020-09-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-192020-10-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US208-1016US2081016BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1017US2081017BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US208-1018US2081018AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-302020-06-30BB mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-082020-07-08B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1019US2081019ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AAScreening SCREENING 2020-05-282020-05-28PP mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-06-292020-06-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-152020-07-15B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-032020-11-18BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2; Local Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1020US2081020BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12CC mRNA-1273-P201SVmRNA-1273-P201-US208-1021US2081021AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US208-1022US2081022AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1023US2081023BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17C@C@ mRNA-1273-P201SVmRNA-1273-P201-US208-1024US2081024AAScreening SCREENING 2020-05-282020-05-28.. mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AAScreening SCREENING 2020-05-282020-05-28`` mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-032020-06-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B1B1 mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BABA mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-262020-08-26BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-232020-09-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-212020-10-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CC mRNA-1273-P201SVmRNA-1273-P201-US208-1025US2081025BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-122021-03-12CC mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AAScreening SCREENING 2020-05-292020-05-29`` mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-072021-01-07BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1026US2081026BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1027US2081027AAScreening SCREENING 2020-05-292020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1028US2081028BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-242020-08-24BTBT mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1029US2081029BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17CPCP mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-062020-07-06B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-132020-07-13B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B1B1 mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-032020-08-03B?B? mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1030US2081030AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1031US2081031AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1032US2081032AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-172020-06-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-172020-06-17BBPregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06BBBB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-052021-01-05BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-252021-01-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1033US2081033BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15C0C0 mRNA-1273-P201SVmRNA-1273-P201-US208-1034US2081034AAScreening SCREENING 2020-05-292020-05-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AAScreening SCREENING 2020-05-292020-05-29@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-022020-06-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-082020-06-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-012020-07-01BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-092020-07-09B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-162020-07-16B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-07-282020-07-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-132020-08-13BIBICentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-252020-08-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-222020-09-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-202020-10-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1035US2081035BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AAScreening SCREENING 2020-05-292020-05-29`` mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036A0A (\(Visit 1 Day 1 Unscheduled 1 .BLINDED TREATMENT 2020-06-062020-06-06A0A0Physical Exam; Vital Signs mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-11-202020-11-20BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036AAQPSafety Call Day 169 Unscheduled 2 .PART A FOLLOW-UP 2020-12-152020-12-15BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036BASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1036US2081036BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CC mRNA-1273-P201SVmRNA-1273-P201-US208-1037US2081037AAScreening SCREENING 2020-05-292020-06-12.. mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AAScreening SCREENING 2020-06-012020-06-01pp mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038A A(\)Screening Unscheduled 1 .SCREENING 2020-06-042020-06-04@@Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1038US2081038BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CPCP mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AAScreening SCREENING 2020-06-012020-06-01pp mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-262020-06-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-162020-07-16B'B'Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-042020-09-04BYBYCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-042021-01-04BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1039US2081039BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US208-1040US2081040AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-112020-08-11BEBE mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-222020-10-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2020-12-212020-12-21BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1041US2081041BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AAScreening SCREENING 2020-06-012020-06-01 mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-102020-06-10AA mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-172020-06-17AA mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24AA mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-022020-09-02BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-302020-09-30BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-282020-10-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-252020-11-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1042US2081042BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1043US2081043AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US208-1044US2081044AAScreening SCREENING 2020-06-012020-06-01.. mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AAScreening SCREENING 2020-06-012020-06-0100 mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-042020-06-04AA mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-112020-06-11AA mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-182020-06-18AA mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-06-252020-06-25BBCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-072020-07-07B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-202020-07-20B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07BABA mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-272020-08-27BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-242020-09-24BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-072021-01-07BB mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1045US2081045BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AAScreening SCREENING 2020-06-022020-06-02`` mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-242020-06-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-242020-07-24B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-09-302020-09-30BsBsCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-302020-10-30BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046BA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-252021-01-25BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1046US2081046BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-232021-02-23CPCP mRNA-1273-P201SVmRNA-1273-P201-US208-1047US2081047AAScreening SCREENING 2020-06-022020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US208-1048US2081048AAScreening SCREENING 2020-06-022020-06-02.. mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AAScreening SCREENING 2020-06-022020-06-02pp mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-092020-06-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23AA mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B;B; mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1049US2081049AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1050US2081050AAScreening SCREENING 2020-06-022020-06-05.. mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-142020-07-14B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10BCBC mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1051US2081051BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17C C mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AAScreening SCREENING 2020-06-022020-06-0200 mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B?B? mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-10-272020-10-27BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052BBSafety Call Day 265 CPART A FOLLOW-UP 2021-02-222021-02-22CpCp mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052BB\(Safety Call Day 265 Unscheduled 1 .PART A FOLLOW-UP 2021-02-222021-02-22CpCpCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1052US2081052BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-122021-03-12CC mRNA-1273-P201SVmRNA-1273-P201-US208-1053US2081053AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-212020-07-21B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-282020-12-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1054US2081054BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US208-1055US2081055AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US208-1056US2081056AAScreening SCREENING 2020-06-032020-06-03.. mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AAScreening SCREENING 2020-06-032020-06-03 mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-052020-06-05AA mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-122020-06-12AA mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-192020-06-19AA mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B1B1 mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-052020-08-05B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-282020-08-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-252020-09-25BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-232020-10-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-292020-12-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1057US2081057BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24CC mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AAScreening SCREENING 2020-06-042020-06-04@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058A@A@Visit 3 Day 15 APART A FOLLOW-UP 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058APAPVisit 4 Day 29 BPART A FOLLOW-UP 2020-07-062020-07-06BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058A`A`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-07-142020-07-14B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058ApApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-07-212020-07-21B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-032020-09-03BXBX mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1058US2081058BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-192021-02-19CC mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AAScreening SCREENING 2020-06-042020-06-04@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-162020-06-16AA mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-132020-07-13B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-202020-07-20B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-272020-07-27B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-102020-08-10B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AA(\(Visit 7 Day 57 Unscheduled 1 .PART A FOLLOW-UP 2020-08-102020-08-10B@B@Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-012020-09-01BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-292020-09-29BrBr mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-272020-10-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1059US2081059BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US208-1060US2081060AAScreening SCREENING 2020-06-042020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US208-1061US2081061AAScreening SCREENING 2020-06-042020-06-04.. mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-172020-07-17B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-052021-01-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062AASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1062US2081062BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-222020-06-22AA mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-082020-07-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-152020-07-15B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-07-152020-07-15B&B&Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-222020-07-22B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-062020-08-06B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-222020-12-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1063US2081063BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24C`C` mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AAScreening SCREENING 2020-06-052020-06-0500 mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-082020-06-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-06-152020-06-15AA mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-06-232020-06-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-092020-07-09B B mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064A`AP(\(Visit 4 Day 29 Unscheduled 1 .BLINDED TREATMENT 2020-07-102020-07-10B!B!Physical Exam; Local Diagnostic Test mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-07-162020-07-16B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-07-232020-07-23B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-072020-08-07B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AASafety Call Day 85 BUPART A FOLLOW-UP 2020-08-312020-08-31BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AASafety Call Day 113 BqPART A FOLLOW-UP 2020-09-282020-09-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AASafety Call Day 141 BPART A FOLLOW-UP 2020-10-262020-10-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AASafety Call Day 169 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AASafety Call Day 197 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064BASafety Call Day 237 BPART A FOLLOW-UP 2021-01-292021-01-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064BA(\(Safety Call Day 237 Unscheduled 1 .PART A FOLLOW-UP 2021-02-152021-02-15BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1064US2081064BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26CC mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1065US2081065ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-112020-08-11B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-252020-08-25B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1066US2081066ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1067US2081067AAScreening SCREENING 2020-06-112020-06-11.. mRNA-1273-P201SVmRNA-1273-P201-US208-1068US2081068AAScreening SCREENING 2020-06-112020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AAScreening SCREENING 2020-06-112020-06-11 mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069A A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-242020-08-24B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-282020-09-28B_B_Physical Exam mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-062021-01-06BB mRNA-1273-P201SVmRNA-1273-P201-US208-1069US2081069BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-212020-09-21BXBXCentral Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1070US2081070ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AAScreening SCREENING 2020-06-122020-06-12 mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1071US2081071ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1072US2081072ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-242020-07-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-032020-08-03B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-102020-08-10B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-212020-08-21B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-282020-09-28B_B_Central Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US208-1073US2081073BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1074US2081074AAScreening SCREENING 2020-06-152020-06-15.. mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AAScreening SCREENING 2020-06-152020-06-15 mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2020-12-302020-12-30BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1075US2081075BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076A@A0(\(Visit 2 Day 8 Unscheduled 1 .BLINDED TREATMENT 2020-07-092020-07-09AAPregnancy Test mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-122020-08-12B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B3B3 mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-032020-09-03BABA mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-182020-11-18BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1076US2081076BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-242021-02-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AAScreening SCREENING 2020-06-162020-06-16 mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B#B# mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B?B? mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077AA(\(Visit 8 Day 209 Unscheduled 1 .PART A FOLLOW-UP 2021-01-222021-01-22BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1077US2081077BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1078US2081078AAScreening SCREENING 2020-06-162020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US208-1079US2081079AAScreening SCREENING 2020-06-172020-06-17.. mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B;B; mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1080US2081080ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AAScreening SCREENING 2020-06-172020-06-17 mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1081US2081081ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1082US2081082AAScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US208-1083US2081083AAScreening SCREENING 2020-06-182020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US208-1083US2081083A A(\)Screening Unscheduled 1 .SCREENING 2020-06-302020-06-30..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1084US2081084AAScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-112020-08-11B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-182020-08-18B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-262020-08-26B7B7 mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BDBD mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AAVisit 8 Day 209 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085AASafety Call Day 237 BPART A FOLLOW-UP 2021-02-252021-02-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1085US2081085BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-03-032021-03-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1086US2081086AAScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-172020-11-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1087US2081087ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AAScreening SCREENING 2020-06-182020-06-18 mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1088US2081088ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1089US2081089AAScreening SCREENING 2020-06-182020-06-18.. mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25``Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-022020-09-02B@B@ mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BrBr mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-142020-12-14BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090AA(\(Safety Call Day 169 Unscheduled 1 .PART A FOLLOW-UP 2021-01-152021-01-15BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090BASafety Call Day 237 BPART A FOLLOW-UP 2021-02-222021-02-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1090US2081090BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-262021-02-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091A A(\)Screening Unscheduled 1 .SCREENING 2020-06-252020-06-25Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B B mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B'B' mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1091US2081091BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B:B: mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1092US2081092ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AAScreening SCREENING 2020-06-192020-06-19 mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-192020-08-19B1B1 mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-09-302020-09-30B[B[Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1093US2081093BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1094US2081094AAScreening SCREENING 2020-06-192020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US208-1095US2081095AAScreening  2020-06-182020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1095US2081095A A(\)Screening Unscheduled 1 .SCREENING 2020-06-242020-06-24..PPD GCL Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1096US2081096AAScreening SCREENING 2020-06-192020-06-19.. mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B;B; mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BVBV mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BsBs mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-11-232020-11-23BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1097US2081097BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1098US2081098AAScreening SCREENING 2020-06-222020-07-01.. mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AAScreening SCREENING 2020-06-222020-06-22@@ mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-262020-06-26AA mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-132020-07-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-062020-08-06B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-182020-09-18BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-162020-10-16BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AA(\(Safety Call Day 113 Unscheduled 1 .PART A FOLLOW-UP 2020-11-062020-11-06BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-132020-11-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-112020-12-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-082021-01-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1099US2081099BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AAScreening SCREENING 2020-06-222020-06-22 mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B/B/ mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-102020-09-10BGBG mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1100US2081100ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1101US2081101AAScreening SCREENING 2020-06-222020-06-22.. mRNA-1273-P201SVmRNA-1273-P201-US208-1102US2081102AAScreening SCREENING 2020-06-222020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1102US2081102A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-222020-07-22BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1103US2081103BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-222020-07-22BBCentral Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-062020-08-06B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-132020-08-13B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-132020-08-13B+B+Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-202020-08-20B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-012020-09-01B>B> mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-142021-01-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104BAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1104US2081104BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1105US2081105AAScreening SCREENING 2020-06-232020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US208-1106US2081106AAScreening SCREENING 2020-06-232020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US208-1107US2081107AAScreening SCREENING 2020-06-232020-06-23.. mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-172020-08-17B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AA(\(Safety Call Day 85 Unscheduled 1 .PART A FOLLOW-UP 2020-10-162020-10-16BjBjCentral Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1108US2081108BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-082021-02-08BB mRNA-1273-P201SVmRNA-1273-P201-US208-1109US2081109AAScreening SCREENING 2020-06-232020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1109US2081109A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26..Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AAScreening SCREENING 2020-06-232020-06-23 mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110A A(\)Screening Unscheduled 1 .SCREENING 2020-06-262020-06-26ppCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-252020-09-25BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-202021-01-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1110US2081110BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-122021-02-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1111US2081111AAScreening SCREENING 2020-06-242020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-032020-07-03AA mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-202020-07-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-112020-08-11B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-192020-08-19B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-262020-08-26B7B7 mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-142020-09-14BJBJ mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BXBX mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-232020-10-23BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-202020-11-20BB mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-182020-12-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-272021-01-27BB mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112AASafety Call Day 237 B .. mRNA-1273-P201SVmRNA-1273-P201-US208-1112US2081112BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113A A(\)Screening Unscheduled 1 .SCREENING 2020-07-032020-07-03PPCentral Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-172020-07-17AA mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-232020-07-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B"B" mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-182020-08-18B*B* mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-242020-08-24B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08B?B? mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-302020-09-30BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-282020-10-28BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-252020-11-25BB mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AA(\(Safety Call Day 141 Unscheduled 1 .PART A FOLLOW-UP 2020-12-182020-12-18BBCentral Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-232020-12-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-212021-01-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1113US2081113BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-172021-02-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1114US2081114AAScreening SCREENING 2020-06-242020-07-02.. mRNA-1273-P201SVmRNA-1273-P201-US208-1115US2081115AAScreening SCREENING 2020-06-242020-06-24.. mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AAScreening SCREENING 2020-06-242020-06-24PP mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-292020-06-29AA mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-072020-07-07AA mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-132020-08-13B.B. mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-272020-08-27B<B< mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-212020-09-21BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-192020-10-19BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-162020-11-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-142020-12-14BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-112021-01-11BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-222021-01-22BB mRNA-1273-P201SVmRNA-1273-P201-US208-1116US2081116ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-142020-07-14AA mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-182020-08-18B,B, mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-252020-08-25B3B3 mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BABA mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-232020-11-23BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1117US2081117ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-052021-02-05BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AAScreening SCREENING 2020-06-242020-06-24pp mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-07-312020-07-31BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-072020-08-07B&B& mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-142020-08-14B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-282020-08-28B;B; mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-192021-01-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1118US2081118ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-212020-07-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-112020-08-11B%B% mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-192020-08-19B-B- mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-252020-08-25B3B3 mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BABA mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US208-1119US2081119ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AAScreening SCREENING 2020-06-242020-06-24pp mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120A A(\)Screening Unscheduled 1 .SCREENING 2020-06-292020-06-29 Central Laboratory mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120A0A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-012020-07-01AA mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120A@A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-092020-07-09AA mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120APA@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-162020-07-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-07-292020-07-29BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120ApA`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-052020-08-05B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-122020-08-12B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-262020-08-26B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-232020-09-23BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-212020-10-21BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-162020-12-16BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-132021-01-13BB mRNA-1273-P201SVmRNA-1273-P201-US208-1120US2081120ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AAScreening SCREENING 2020-06-242020-06-24 mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-062020-07-06AA mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-132020-07-13AA mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17AA mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-102020-08-10B$B$ mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-172020-08-17B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-242020-08-24B2B2 mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-042020-09-04B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-282020-09-28BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-262020-10-26BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-242020-11-24BB mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-212020-12-21BB mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-182021-01-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121AAVisit 8 Day 209 B .. mRNA-1273-P201SVmRNA-1273-P201-US208-1121US2081121ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-032021-02-03BB mRNA-1273-P201SVmRNA-1273-P201-US208-1122US2081122AAScreening SCREENING 2020-06-252020-06-30.. mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AAScreening SCREENING 2020-06-252020-06-25PP mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123A A Visit 1 Day 1 ABLINDED TREATMENT 2020-06-302020-06-30AA mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08AA mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-152020-07-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123APA@(\(Visit 3 Day 15 Unscheduled 1 .BLINDED TREATMENT 2020-07-292020-07-29BBVital Signs; Central Laboratory; Central Laboratory - Antibody-Mediated Immunogenicity; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123A`APVisit 4 Day 29 BBLINDED TREATMENT 2020-08-112020-08-11B+B+ mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123ApA`Visit 5 Day 36 B$PART A FOLLOW-UP 2020-08-192020-08-19B3B3 mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AApVisit 6 Day 43 B+PART A FOLLOW-UP 2020-08-252020-08-25B9B9 mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-09-082020-09-08BGBG mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-222020-09-22BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-202020-10-20BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-182020-11-18BB mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-152020-12-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-122021-01-12BB mRNA-1273-P201SVmRNA-1273-P201-US208-1123US2081123AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-262021-01-26BB mRNA-1273-P201SVmRNA-1273-P201-US208-1124US2081124AAScreening SCREENING 2020-06-252020-06-29.. mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AAScreening SCREENING 2020-06-252020-06-25pp mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-112020-08-11B)B) mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125ApApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-182020-08-18B0B0 mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1125US2081125ABParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-022021-02-02BB mRNA-1273-P201SVmRNA-1273-P201-US208-1126US2081126AAScreening SCREENING 2020-06-252020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US208-1127US2081127AAScreening SCREENING 2020-06-252020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US208-1128US2081128AAScreening SCREENING 2020-06-252020-06-25.. mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AAScreening SCREENING 2020-06-252020-06-25pp mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129A A Visit 1 Day 1 ABLINDED TREATMENT 2020-07-022020-07-02AA mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129A0A0Visit 2 Day 8 ABLINDED TREATMENT 2020-07-082020-07-08ApAp mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129A@A@Visit 3 Day 15 ABLINDED TREATMENT 2020-07-172020-07-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129APAPVisit 4 Day 29 BBLINDED TREATMENT 2020-08-032020-08-03B!B! mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129A`A`Visit 5 Day 36 B$BLINDED TREATMENT 2020-08-102020-08-10B(B( mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129ApA`(\(Visit 5 Day 36 Unscheduled 1 .BLINDED TREATMENT 2020-08-102020-08-10B(B(Central Laboratory; Central Laboratory - Nasopharyngeal Swab and Blood Collection for SARS-CoV-2 mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AApVisit 6 Day 43 B+BLINDED TREATMENT 2020-08-242020-08-24B6B6 mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AAVisit 7 Day 57 B9PART A FOLLOW-UP 2020-08-312020-08-31B=B= mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AASafety Call Day 85 BUPART A FOLLOW-UP 2020-09-242020-09-24BUBU mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AASafety Call Day 113 BqPART A FOLLOW-UP 2020-10-222020-10-22BqBq mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AASafety Call Day 141 BPART A FOLLOW-UP 2020-11-192020-11-19BB mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AASafety Call Day 169 BPART A FOLLOW-UP 2020-12-172020-12-17BB mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AASafety Call Day 197 BPART A FOLLOW-UP 2021-01-152021-01-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129AAVisit 8 Day 209 BPART A FOLLOW-UP 2021-01-282021-01-28BB mRNA-1273-P201SVmRNA-1273-P201-US208-1129US2081129BBParticipant Decision Visit / OL-D1.PART A FOLLOW-UP 2021-02-152021-02-15BB mRNA-1273-P201SVmRNA-1273-P201-US208-1130US2081130AAScreening SCREENING 2020-06-252020-06-29..